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With the advent of antiretroviral therapy, the HIV pandemic has become a chronic illness 
requiring lifelong treatment. The 90-90-90 strategy, adopted by UNAIDS, aims for (i) 90% of HIV 
infected persons knowing their status, (ii) 90% on antiretroviral therapy; and (iii) 90% achieving viral 
suppression. The goal is to reach these aims by 2020.  Alcohol use affects the attainment of the 90-
90-90 goals. Research shows that people living with HIV (PLWH) drink twice as much as their HIV 
negative counterparts.  Alcohol use disorders (AUD) in PLWH are associated with poor adherence to 
ART. Recommendations have been made to include interventions for AUDs in HIV prevention and 
treatment strategies. Brief interventions are recommended for hazardous alcohol use; however, for 
alcohol dependence a stepped care model incorporating behavioural/psychological treatments and 
pharmacological interventions may be required. Pharmacological treatments may lead to a higher pill 
burden and psychological interventions are, therefore, the treatment of choice. Psychological 
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interventions have traditionally been delivered by a highly skilled workforce. However, in low and 
medium income countries (LMIC) where the HIV prevalence is high, there is a shortage of a skilled 
workforce.  Task sharing has been recommended as a way of scaling up the delivery of services. 
 
        The aim of this study was to adapt an evidence-based intervention for HIV and AUDs in 
Zimbabwe and to assess its effectiveness 
       in a cluster randomized controlled trial (RCT). To achieve this, we first conducted a 
systematic review of the evidence for the effectiveness of psychological interventions. Second, a 
qualitative study was done to understand knowledge and perceptions of AUDs among PLWH and 
potential barriers and facilitators of interventions for AUDs. Third, we conducted a pilot and feasibility 
study in preparation for the RCT. 
      The systematic review found limited evidence for the effectiveness of psychological 
interventions for AUDs, particularly on the frequency of drinking. Motivational interviewing (MI) 
alone and in combination with mobile technology, and cognitive behavioural therapy (CBT) were 
found to be effective.  Additionally, MI was effective in reducing risky sexual behaviour, adherence 
to ART, other substance use disorders, viral load reduction, and increase in CD4 count. The qualitative 
study found that PLWH had adequate knowledge of the direct and indirect effects of alcohol use on 
HIV transmission and adherence to treatment, and were concerned about the stigma faced by PLWH 
who have and AUDs. 
          Furthermore, participants were concerned about the stigma faced by PLWH who have 
AUDs. They called for stigma reduction strategies to be implemented and were receptive of the idea 
of interventions for AUDs. 
       Following a pilot study which indicated that an intervention for AUDs was feasible, a 
cluster RCT was carried out at 16 HIV care clinics. The adapted intervention included motivational 
interviewing blended with cognitive behavioural therapy (MI/CBT). The comparator intervention was 
Stellenbosch University  https://scholar.sun.ac.za
v 
 
the alcohol use section of the World Health Organisation (WHO) mental health Gap Action Program 
Intervention Guide (mh GAP IG). The MI/CBT and mh GAP IG interventions were delivered by 
registered general nurses (RGN) embedded in HIV care clinics. The primary outcome was a reduction 
in alcohol use as measured by the Alcohol Use Disorders Identification Test (AUDIT) score.  Secondary 
outcome measures included: (i) HIV disease parameters, as measured by the viral load and CD4 count; 
(ii) functionality, as assessed by the WHO Disability Assessment Schedule (WHODAS 2.0); and (iii) 
quality of life, as measured by the WHO Quality of Life HIV (WHOQOL HIV).  
      The cluster RCT demonstrated that RGNs can be trained to deliver an MI/CBT intervention 
for AUDs in PLWH. Additionally, the MI/CBT intervention significantly reduced alcohol consumption 
in PLWH. While the reduction in alcohol consumption was maintained in the MI/CBT arm at 6 months, 
this effect was only maintained in the mh GAP IG arm up to 3 months. Additional improvements were 
seen in HIV treatment outcomes (especially viral load), functionality, and quality of life. Finally, it was 
feasible to deliver an MI/CBT intervention using a task sharing model. In terms of implementation, 
this can be done with a modest increase in staffing. Given the negative role AUDs play in the HIV 
treatment cascade, reduction in alcohol use can help in achieving the UNAIDS’ 90-90-90 goals.  
       Further, effectiveness trials are needed in LMIC with a high prevalence of HIV. When 
conducting these trials, attention should be paid to patient experiences, such as the ‘double’ stigma 
of HIV and AUDs.  
  




       HIV het ŉ kroniese siekte geword as gevolg van antiretrovirale tarapie. UNAIDS het die 90-
90-90 strategie begin. Die strategie beoog dat: (i) 90% van HIV-positiewe mense hulle status moet 
ken; (ii) 90% moet antiretrovirale terapie (ART) ontvang; en (iii) 90% moet virale-onderdrukking 
bereik. UNAIDS beoog om die doelwitte teen 2020 te bereik. Alkoholgebruik beïnvloed die 90-90-90 
strategie. Navorsing toon that mense wat met HIV leef (MHL) twee keer soveel alkohol drink as mense 
wat HIV-negatief is. Alkoholmisbruikversteurings (AMVs) word met swak nakoming vir 
antiretroviralebehandeling (ARB) geassosieer. Intervensies vir AMVs, as deel van HIV voorkoming en 
behandeling, word aanbeveel. Kort intervensies word vir gevaarlike alkoholgebruik aanbeveel, maar 
vir alkoholafhanklikheid is ŉ trap-vir-trap versorgings model wat gedrags/sielkundige- en 
farmakologiesebehandeling insluit moontlik nodig. Tog mag farmakologiesebehandeling tot ŉ hoër 
medikasie-lading lei. Geveloglik, is sielkundige intervensies ŉ beter keuse. Sielkundige intervensies 
word grotendeels deur hoogs-geskoolde werkers, wat nie in lae-middel inkomste lande (LMIL) waar 
HIV baie voorkom, volop beskikbaar is nie, aangebied. Taakdeling word aanbeveel as oplossing om 
die tekort aan hoogs geskoolde werkers aan te spreek.  
       Hierdie studie beoog om ŉ bewys-gebasseered intervensie vir HIV en AMVs vir Zimbabwe 
aan te pas, sowel as om die effektiwiteit daarvan deur middel van ŉ groepe-ewekansige-beheerde-
toets (GEBT) te bepaal. Om dit te doen het ons eerste ŉ sistematiese-literatuuroorsig oor die 
effektiwiteit van sielkundige intervensies gedoen. Dit is gevolg deur ŉ kwalitatiewe studie met die 
doel om die kennis en persepsies van AMVs, sowel as moontlike hindernisse en fasiliteerders van 
AMVs; onder MHL te verstaan. Ten derde het ons ŉ toets- en proefstudie in voorbereiding vir die 
GEBT gedoen.   
        Die sistematiese-literatuuroorsig het weinige bewyse vir die effektiwiteit van sielkundige 
intervensies vir AMVs, veral in terme van die frekwensie van gebruik, getoon. 
Motiversingonderhoudvoering (MO), met en sonder die gebruik van selfoontegnelogie, en 
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kognitiewegedragsterapie (KGT) is gevind om effektief te wees. Verdermeer is MO effektief in die 
vermindering van gevaarlike seksuele gedrag, die nakoming van ART, behandeling van ander 
substansmisbruikversteurings, die vermindering van viralelading, en die verhoging van CD4 tellings. 
Die kwalitatiewestudie het gevind dat MHL voldoende kennis van die direkte en indirekte invloed van 
alkoholverbruik op HIV oordrag en behandeling, het. Verdermeer het deelnemers daarop gedui dat 
hulle oor die stigma van MHL wat ook AMVs het, besorg is. Hulle het gevra dat strategieë wat die 
stigma verminder geimplimenteer moet word. MHL was ontvanklik in terme van AMV intervensies.  
         Nadat die proefstudie daarop gedui het dat ŉ intervensie vir AMVs doenbaar is, is ŉ GEBT 
by 16 HIV-versorgingsklinieke uitgevoer. Die studie intervensies het gemengde 
motiveringsonderhoudvoering/kognitiewe gedragsterapie (MO/KGT) en die WHO se mh GAP 
intervensiegids (mh GAP IG) ingesluit. Geregistreerde algemene verpeegsters (GAV) by HIV-
versorgingsklinieke het die intervensies aangebied. Die vermindering van alkoholverbruik, soos deur 
die Alcohol Use Disorders Identification Test (AUDIT) gemeet, het as primêre uitkomste gedien. Die 
volgende het as sekondêre uitkomstes gedien: (i) HIV parameters, soos deur die viralelading en CD4 
telling gemeet; (ii) funksionaliteit, soos deur die WHO Disability Assessment Schedule weergawe 2 
(WHODAS 2.0) gemeet; en (iii) lewenskwaliteit, soos deur die WHO Quality of Life HIV (WHOQOL HIV) 
gemeet.  
       Die GEBT het getoon dat GAV opgelei kan word om die MO/KGT intervensie vir MHL met 
AMV aan te bied. Verdermeer het die MO/KGT intervensie ŉ beduidende effek op die verminering 
van alkoholverbruik van MHL gehad. Die effek van die mh GAP IG intervensie is vir 3 maande 
volgehou, terwyl die effek van die MO/KGT vir 6 maande volgehou is. Daar is ook gevind dat ŉ 
vermindering in alkoholverbruik HIV terapie uitkomste verbeter, veral soos aangedui deur die 
vermindering in viralelading. Funksionaliteit en lewenskwaliteit het ook as gevolg van die intervensie 
verbeter. Laastens is dit bevind dat die lewering van ŉ MO/KGT intervensie deur middel van 
taakdeling, geldig is. Die implementasie van ŉ MO/KGT kan met ŉ matige vermeedering van die 
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werksmag gedoen word.  Gegewe die negatiewe effek van AMVs op die behandeling van MHL kan 
die vermindering van alkoholverbruik help om die UNAIDS se 90-90-90 doelwit te bereik. 
      Verdere kliniese toetsings van die effektiwiteit van intervensies in LMIL met ŉ hoë HIV 
voorkoms, is nodig. Wanneer die toetsings toegepas word, moet daar aandag aan die dubbele-stigma 
van beide HIV en AMVs verleen word.  
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Since the beginning of the HIV pandemic in the 1981, it has caused 35 million deaths, 37 
million are living with the infection, 1.9 million were infected in 2016 alone, 20.9 million were on 
antiretroviral therapy as at June 2017, and by 2020 US$ 26.2 billion will be required to address 
HIV/AIDS in low and middle income countries(1). Although the first HIV infection was documented 
among injection drug users and gay men in the USA (2), in Sub-Saharan Africa the main mode of 
infection is through heterosexual contact with prevalence higher in females (3). Sub Saharan Africa 
has two thirds of all infections at 25 million(4). Zimbabwe has 1.6 million PLWH with 75% cognisant 
of their HIV status; 75% of those infected are on antiretroviral treatment and 64% have achieved viral 
suppression according to a recent population based survey (5, 6).  
Mental illness is associated with poor HIV disease treatment outcomes according to 
research(7). PLWH are at increased risk of mental illness, with more than twice the risk of depression, 
alcohol and substance use and anxiety disorders among this population (8-10). Mental illness has 
been shown to have adverse effects on adherence to antiretroviral therapy resulting in poor 
treatment outcomes (11). Alcohol and substance use disorders have been implicated particularly in 
non-adherence more than other mental disorders (12). Research suggests that a hazardous alcohol 
use relationship with poor HIV treatment outcomes is through lack of adherence to treatment and 
exacerbated by nutrition insufficiency among other factors (13, 14).  
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Alcohol Use and HIV transmission 
Drinking increases the risk of HIV infection according to research (15); (16, 17). The increased 
risk of HIV infection is related to behavioural factors such as sexual encounters with at-risk 
populations and unprotected sex; and biological factors such as (18). Alcohol consumption leads to 
risky sexual behaviour, increased unprotected sex, transactional sex and multiple sexual partners (19, 
20). Alcohol-serving venues are frequently patronised by individuals who have multiple sex partners 
and who engage in transactional sex (21, 22). Further, alcohol use has been associated with increased 
prevalence of sexually transmitted infections related to unprotected sex (23). This is important as HIV 
infection requires a breach in the vaginal and penile epithelium which is facilitated by sexually 
transmitted infection (24). Alcohol use increases the incidence of bacterial vaginosis that enhances 
the risk of acquiring sexually transmitted infection (25). Further, there is increased infectiousness in 
women who drink due to the accumulation of monocytic phagocytes which are the targets of the HIV 
virus. Breach in the epithelium and presence of T-cells processes (which are the targets of HIV virus) 
predominate the valvular area (26, 27).  
Unhealthy alcohol use and the HIV treatment cascade 
There is evidence that individuals who drink alcohol are less likely to present for HIV testing 
or delay in HIV testing, and delay in the commencement of antiretroviral therapy (ART)(28). By the 
time these individuals commence HIV treatment they are at an advanced stage of HIV disease and 
are likely to have poor treatment outcomes (29). Alcohol, HIV and hepatitis C lead to hepatic failure 
and thus adversely affect the metabolism of antiretroviral agents (30). Failure to metabolise leads to 
increased antiretroviral drug toxicity and associated frailties (29).  
Alcohol use and adherence 
The association between alcohol consumption and poor treatment adherence is well 
established (11; 31-34). Both the frequency and quantity of drinking result in poor adherence to HIV 
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treatment (33, 35). AUDs often concur with depression and both of which have been associated with 
poor adherence to ART (36, 37). Alcohol consumption is associated with cognitive impairment  that 
cause patients to forget to take their antiretroviral drugs or take them out of time (38). Studies have 
also shown that some PLWH, through inappropriate HIV treatment education, believe that ARVs and 
alcohol should not be taken together as the combination is poisonous and so they skip medication on 
drinking days (39, 40). Taking medications ‘out of time’ on drinking days leads to suboptimal effects 
of ARVs and lack of viral suppression (40).  
Alcohol consumption and viral suppression and CD4 
AUDs are often associated with poor viral suppression frequently due to poor adherence to 
treatment among other factors (41). Adherence of about 95% or more is required to achieve viral 
suppression. PLWH with drinking problems, especially with dependence, have been shown to have 
low CD4 (42). However, hazardous use of alcohol and recent commencement on ART do not change 
the levels of CD4 (43, 44). Virological failure in alcohol drinking PLWH is mainly due to poor adherence 
to ART (41, 45) but other factors such as concurrent mental health problems and nutrition may be 
contributory (13).  
Safe drinking and the HIV cascade 
The National Institutes of Alcohol Abuse and Alcoholism (NIAAA) recommends safe drinking 
of 14 units per week for females and 21 units per week for males (46). However, safe drinking that 
applies to HIV negative individuals may not be applicable to PLWH, as studies have shown that PLWH 
need less alcohol to experience a ‘buzz’ or to feel intoxicated (35). This is important in screening and 
brief interventions. The drinking levels need to be reduced in PLWH. 
Research has shown that compared with HIV negative individuals, PLWH suffer more 
physiologic harm from alcohol consumption (47). PLWH who have not achieved viral suppression 
need less alcohol to get drunk compared with those who have achieved viral suppression (48, 49) 
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which suggests that the adjustments of daily allowable alcohol need to be different within the PLWH 
themselves.  
In females, binge drinking has been shown in experimental studies (50)to cause changes in 
the vaginal flora and increased inflammatory activities. As a result, females PLWH with AUDs have 
also been shown to be more infectious, compared to those who do not drink (26, 51).  
Assessment of alcohol use 
Currently, multiple ways of assessing alcohol consumption are in use including self-report 
questionnaire and biological (surrogate) measures. The self-report assessment includes the Alcohol 
Use Disorders Identification Test (AUDIT) and AUDIT C, (a short version) and the Cut-Annoyed-Guilty-
Eye opener (CAGE). While the self-report questionnaires are relatively easy and less expensive to 
administer, their main drawback is social desirability bias, whether interviewer administered or 
through electronic medical record (ACASI)(52-54). The surrogate measures include liver enzyme 
especially the gamma glutamyl transferase (GGT), and the mean corpuscular volume. Other 
biomarkers include phosphotidylethanol (PE) and ethyl glucuronide (EtG). PE has been found to be 
robust in assessing alcohol use levels and treatment progress (55, 56). EtG which is found in hair and 
urine has been found to be especially sensitive and highly specific in assessing recent alcohol 
consumption (57). GGT and MCV changes can be caused by a variety of conditions and may take 
longer to correct. PE and EtG are expensive and may be unaffordable in low and middle income 
countries (58). Yet, screening for alcohol use is an important component of treatment. Screening and 
Brief Interventions (SBIs) have the most evidence for effectiveness and are recommended by many 
guidelines for treatment of problematic alcohol use in the general population (59). 
Alcohol Interventions in PLWH 
Alcohol consumption is recognised as one of the modifiable risk factors for failure to control 
the HIV pandemic (31) but, despite the availability of many evidence-based alcohol use therapies, 
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few have proved to be effective  in reducing alcohol use in PLWH (60). On a positive note, a recent 
meta-analysis by Scott-Sheldon found behavioural interventions effective for reducing alcohol use 
and other behaviours such as risky sex in PLWH (61). Some other explanations for lack of effectiveness 
are the presence of multiple morbidities in HIV; the extent of alcohol use; the differences in the levels 
of experience in intervention staff and the number of sessions given (60). As drinking differs in 
severity, PLWH with alcohol dependence may benefit from stepped-up models of care (62). As such, 
adjuvant pharmacological interventions may be needed to complement psychotherapeutic and 
psychosocial modalities (63). 
Some commonly used evidence-based treatments for problematic drinking include 
motivational therapies; cognitive behaviour therapies (CBT); problem solving; risk reduction; and 
twelve step facilitations (TSF) (60). However, many individual studies have marked heterogeneity in 
treatment modality to allow for reviews with meta-analysis to find the treatments that have notable 
treatment effect (60). In order to improve alcohol use treatment outcomes, combinations of these 
evidence-based therapies are indicated. Some of the treatment combinations are motivational 
interviewing and CBT such as problem solving and risk reduction (64). Findings on the effectiveness 
of interventions for hazardous drinking have not been consistent with some only showing effects (60, 
65) and it seems that high levels of alcohol consumption may require more intensive interventions 
(66). The interventions may require a combination of psychological and pharmacological methods in 
a stepped care design (67). However, again due to the multiple co-morbidities, and a high pill burden, 
pharmacological treatments for unhealthy alcohol use may encounter similar adherence challenges 
as with ART.  
Task sharing in alcohol use treatment and HIV care 
Sub-Saharan Africa (SSA) has high prevalence of HIV infections but also faces severe shortages 
of health workers, especially in mental health, owing to HIV deaths, brain drain and natural attrition 
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(68, 69). Further, HIV infection is accompanied by other co-morbid conditions such as depression and 
anxiety which increase the workload and require specialist care (37, 70). Task-sharing has been 
identified as a solution, though it may require further training and additional funding to set up (71). 
Task sharing has been embraced in HIV care settings and has resulted in increased ART coverage, 
suggesting its’ utility in augmenting interventions for alcohol and substance use reduction in PLWH 
to improve treatment outcomes (72, 73). However mental health care has not fully embraced task 
sharing, which has a potential to improve coverage and extend to the difficult to reach population. 
The HIV/Alcohol use situation in Zimbabwe 
Zimbabwe has a high HIV burden and a per capita alcohol consumption of close to 6 litres, 
according to World Health Organisation (WHO) (74). This is higher than the World Health 
Organisation Afro-region of 3.2 litres (WHO 2014). PLWH have high prevalence of alcohol use 
according to research from the United States (9). Therefore, a double burden of HIV and unhealthy 
alcohol use prevails and HIV elimination as espoused by WHO is a challenge in the context of high 
alcohol use prevalence. WHO initiated the ‘test and treat’ policy that stipulates that every person 
testing positive for HIV be commenced on ART. This has led to more people who may not have been 
symptomatic receiving HIV treatment (75). This accords with the 90-90-90 targets as set by the 
UNAIDS, so that by 2020, 90% of people infected with HIV should know their HIV status; 90% be on 
HIV treatment and 90% achieve viral suppression with a view to eliminating HIV by 2030 (76). As a 
result, consistent adherence to ART may be a priority requiring novel strategies to retain PLWH in 
care. 
Policies and strategies to improve HIV coverage require attention to such factors as alcohol 
use treatment within HIV care. However, Zimbabwe ─ like many countries in the SSA region ─ has no 
policies to reduce alcohol consumption among PLWH (77). Calls have been made for implementation 
interventions for unhealthy alcohol use to improve adherence and achieve significant viral 
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suppression. The interventions can lead to ART utilisation for an extended life expectancy through 
reduced risky sexual behaviour and lower rates of new HIV infection (78). However, more research 
needs to be carried out to establish the most efficacious interventions; the clinical situations enabling 
intervention delivery; the required intervention doses to effect change; and cost-effective task-
sharing models that maintain the quality of interventions. The overall purpose of this study was to 
identify the possible components, development of treatment protocols and to ascertain treatment 
efficacy.  
Research question 
Does a behavioural intervention for unhealthy alcohol consumption in PLWH, as offered by 
registered general nurses in a resource limited setting, lead to a reduction in alcohol use (as measured 
by the AUDIT), and an improvement in functional capacity, quality of life and adherence to HAART (as 
measured by the viral load and CD4)? 
Hypothesis 
1. An adapted motivational interviewing/cognitive behavioural therapy (MI/CBT) treatment will lead 
to reduction in unhealthy alcohol use among PLWH.  
2. An adapted MI/CBT treatment to reduce unhealthy alcohol use in PLWH compared to WHO mental 
health GAP Intervention Guide (mh GAP IG) will lead to reduction in alcohol use, adherence to 
HAART and significantly greater improvement in functional capacity and quality of life.  
Specific aims 
1. To evaluate the effect of an adapted motivational interviewing and cognitive behavioural therapy 
(MI/CBT) treatment in people living with AIDS (PLWH) on alcohol use outcomes.  
2. To assess whether an adapted MI/CBT treatment for alcohol use in PLWH compared with the WHO 
mental health GAP Intervention Guide (mh GAP IG) as delivered by Registered General Nurses 
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(RGN) in a task-sharing model will improve functional ability and quality of life. As nurses are not 
usually schooled to provide psychological treatments such as motivational interviewing, this 
treatment trains them to deliver this treatment with the help of a manual. Provision of specialised 
care by health care workers with a lower scope of training is referred to as task-sharing.  
3. To establish whether an adapted MI/CBT intervention for alcohol consumption in PLWH compared 
with mhGAP IG as delivered by RGN can lead to better treatment adherence in Zimbabwe as 
measured by viral loads and CD4. 
General methods 
Full description of the study methodology is included in the accompanying manuscripts.  
Ethical considerations 
The Health Research Ethics Committee (SI14/10/222) of Stellenbosch University, Cape Town, 
and the Medical Research Council of Zimbabwe (A/1936), Harare, Zimbabwe approved the study. 
To inform the development of the treatment, the scope of review interventions for alcohol 
use in general and a systematic review of evidence for the psychological evidence-based therapies 
for unhealthy alcohol use in PLWH in particular was done. Further, a qualitative study to assess the 
perceptions of drinking in the context of HIV was undertaken among 39 PLWH. In-depth interviews 
to assess the facilitators and barriers to intervention for unhealthy alcohol use from a program point 
of view were done with 5 experts in mental health and HIV care. A pilot and feasibility study were 
conducted at a central Zimbabwean hospital among 40 people living with HIV. Finally, to answer our 
research questions, a cluster randomised controlled trial involving 16 HIV care clinics was carried out. 
The accompanying manuscripts show the results of these studies. 




Systematic review of psychological interventions for alcohol use disorders in PLWH  
The systematic review aimed at identifying the appropriate evidence-based treatment and its 
components for development of a treatment for unhealthy alcohol use for PLWH. In this manuscript 
we followed PRISMA guidelines to systematically review the literature on interventions designed to 
test empirically proven psychological interventions for unhealthy alcohol use in PLWH. See methods 
section of the review manuscript. 
Development of the intervention protocol 
The aim of this section of the study was to develop a framework including an outline of the 
treatment arms. We outline the process of developing the MI/CBT intervention arm and mh GAP IG 
control whilst providing background to the assessment measures.  
Qualitative study to understand the effects of drinking in the context of HIV infection 
The study aimed to describe and understand the perceptions and impact of alcohol use in a 
sample of HIV positive individuals. The methods are fully described in the article. 
Pilot and feasibility study of an alcohol use disorder intervention 
The aim of the study was to assess the feasibility of conducting a cluster randomised 
controlled trial on the effectiveness of motivational interviewing/cognitive behavioural therapy 
(MI/CBT) treatment for unhealthy alcohol use compared to the WHO mh GAP IG in PLWH in 
Zimbabwe. The methods are discussed in the manuscript. 
Alcohol use disorders intervention in PLWH in Zimbabwe: a cluster randomised controlled trial (RCT) 
The overall aim of the RCT was to compare the effectiveness of an MI/CBT treatment to mh 
GAP IG on reduction of AUDIT score and HIV treatment outcomes as measured by the viral load and 
CD4; functional capacity as measured by WHODAS 2.0 tool; and quality of life as measured by 
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WHOQOL HIV. We also assessed the feasibility of training RGNs and using them to deliver treatment 
using manuals within the HIV care clinic. The methods used are outlined in the manuscript. 
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Alcohol use in people living with HIV/AIDS impairs quality of life and is a significant impediment in 
achieving HIV viral control. As the focus of HIV treatment has moved towards elimination of the 
disease, alcohol use has been identified as one of the obstacles and treatments for unhealthy alcohol 
use are therefore essential. Psychological interventions may be effective although a systematic 
review published in 2013 was inconclusive. The objectives of the review were to identify the literature 
and synthesize the evidence on the effects of psychological interventions for unhealthy alcohol use 
in people living with HIV/AIDS.  
Methods 
A search was conducted through PubMed (1986-2017); Cochrane Central Register of Trials 
(CENTRAL), MEDLINE (Ovid) (1986-2017; EMBASE (EMBASE.com 1986-2017); PsychInfo (Ovid)(1986-
present); and Clinical trials.gov (clinicaltrials.gov) for eligible studies on 10 July 2017. Two reviewers 
independently screened titles, abstracts, and full texts to select studies that met the inclusion criteria. 
Two reviewers independently performed data extraction.  
Results 
Owing to the high degree of heterogeneity in the outcome measures for alcohol use across studies, 
a meta-analysis was not possible. Fourteen studies met the review inclusion criteria. The majority of 
studies came from the United States and three from Sub-Saharan Africa. Selection, performance and 
attrition biases were deemed to be unclear or high in the included studies. In a narrative synthesis, 
we found beneficial effects for motivational interviewing aided by mobile technology and cognitive 
behavioural therapy (CBT)in individual studies. Of the studies that assessed secondary outcomes, 
there were some effects for motivational interviewing on viral loads, other substance use, risky sexual 
behaviours and adherence to antiretroviral treatment.  





As we were unable to perform a meta-analysis, no definitive conclusions can be drawn about the 
effectiveness of psychological interventions for alcohol use in people living with HIV. There was 
evidence for the effectiveness of motivational interviewing aided by mobile technology and CBT on 
its own. Randomised clinical trials of interventions that incorporate technology and which measure 
alcohol use in a standardised way are needed, especially in low- and middle-income countries. 
Key words: Alcohol, HIV, Systematic, Psychological, Motivational, Cognitive, Interventions, Review 
Systematic Review PROSPERO Registration CRD42017063856 
  
Stellenbosch University  https://scholar.sun.ac.za
22 
 
Background to study 
            It is estimated that 30-50% of people living with HIV also have alcohol use (Azar, 
Springer, Meyer, & Altice, 2010; Galvan et al., 2002). This is important, first, because of the general 
consequences of hazardous alcohol use such as intoxication, accidents, violence, liver disease, and 
cancers. Secondly, PLWH who drink alcohol are more likely to have delayed HIV treatment initiation, 
reduced adherence to antiretroviral therapy (ART), more treatment interruptions and a lower 
chance of achieving viral suppression(Azar et al., 2010). Thirdly, alcohol use is associated with risky 
sexual behaviour, sexually transmitted infections and hence spread of HIV infections(Morrison, 
DiClemente, Wingood, & Collins, 1998; Williams et al., 2016). Viral load suppression is a key target 
in the UNAIDS goals that aim at eliminating HIV by 2030 (Azar et al., 2010). Unhealthy alcohol use is 
also associated with risky sexual behaviour, non-use of condoms, and reduced uptake of pre-
exposure and post-exposure prophylaxis (Van der Elst et al., 2013; van Griensven et al., 2010). 
          Alcohol use disorders (AUDs) are defined in the American Psychiatric Association's 
Diagnostic Statistical Manual version 5 (DSM-5) as “a group of disorders that are caused by the 
consumption of alcohol” (American Psychiatric Association (2013). Diagnostic and statistical manual 
of mental disorders : DSM-5 (5 ed.). Arlington). They include those conditions that were previously 
referred to individually as alcohol abuse and alcohol dependency (VAPA.). Alcohol abuse refers to 
persistent consumption of alcohol despite the presence of physical, psychological, and social 
problems. Alcohol dependence is defined by the presence of tolerance and withdrawal.  
Assessment of individuals with alcohol use is usually through clinical evaluation, biological 
investigations and self-report questionnaires. The biological measures include assessment of blood 
alcohol concentration, or surrogates such as liver transaminases such as gamma glutaryl 
transaminase (GGT), mean corpuscular volume (MCV), or markers such as Phosphotidyl ethanol and 
ethyl glucuronide (EtG) (Eyawo et al., 2018). The self-report assessments include the Cut-Annoyed-
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Guilty-Eye-opener which is a 4-question instrument that assesses mainly the presence of 
dependency, and the Alcohol Use Disorders Identification Test (AUDIT) which is a 10-question 
instrument developed by the World Health Organisation (WHO) which scores from 0 to 40 (Babor TF, 
care., & 1989b.). 
Interventions for reducing alcohol use are heterogeneous and include brief education, 
motivational interviewing and longer interventions based on CBT. At the time we began this study 
there had been two previous systematic reviews in 2010 and 2013 (Azar et al., 2010). Neither of these 
found conclusive evidence that psychological interventions could improve unhealthy alcohol use in 
PLWH, or improve viral suppression. New studies have emerged that address alcohol use in the 
context of HIV treatment (Azar et al., 2010; Hasin et al., 2013; Zule et al., 2014). A systematic review 
and meta-analysis of behavioural interventions for alcohol use in HIV, with a focus on alcohol 
quantity, has reported evidence of behavioural therapies on alcohol use quantities, adherence and 
risky sexual behaviour (Scott-Sheldon, Carey, Johnson, Carey, & Team, 2017). However, this review 
differs from our review as our study specifically examines alcohol use frequency. 
Psychological interventions can be delivered in diverse ways, such as in a group (more than 
one individual) or individual or both; and in different settings including hospital based, community, 
primary care settings or emergency services (Brown, DeMartini, Sales, Swartzendruber, & 
DiClemente, 2013). Improvements in delivery have come through increased use of smartphones and 
other mobile devices (Aharonovich et al., 2006) and, as technology penetration in high endemic areas 
increases, this may be preferable as more people can be reached compared to conventional face-to-
face methods (Forman et al., 2018). Technology based interventions commonly called mHealth 
interventions are a promising group of psychological interventions (Aharonovich, Stohl, Cannizzaro, 
& Hasin, 2017; Murray, Khadjesari, Linke, Hunter, & Freemantle, 2013). 
Brief psychological interventions can be offered in emergency care services in an opportunistic 
way (alcohol use is discussed with patients who are seeking help for other health problems) though 
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subject to limitations occasioned by the lack of space and time (Strauss, Munoz-Plaza, Tiburcio, & 
Gwadz, 2012). The services can also be delivered at family/general practice settings that may offer 
privacy, although many family practitioners avoid discussing alcohol use as they tend to be familiar 
(they have established a relationship) with patients and, indeed, many may be aware of the drinking 
patterns of their clients but avoid the subject due to discomfort (Le et al., 2015). Other family 
practitioners have identified the lack of time and challenging clinical settings that restrict space and 
personal privacy as barriers to the provision of brief psychological screening interventions (Lee, Olsen, 
& Sun, 2017). 
Given that adherence to ART is the single most important determinant of HIV treatment 
outcomes, the effects of an AUD-focused psychological intervention may significantly improve HIV 
treatment outcomes (Gordon et al., 2017). Reviews to date of interventions which targeted 
adherence only without control of unhealthy alcohol use are inconclusive, leading to calls for 
interventions that target both adherence and unhealthy alcohol use (Brown et al., 2013; Samet & 
Walley, 2010). Psychological interventions may be tailored to address comorbid conditions such as 
depression that are also implicated in poor ART adherence 
("<AUD_Depression_Transdiagnostic_WHOSouth-EastAsiaJPublicHealth6150-
4198152_113941.pdf>,"; Balhara, Gupta, & Elwadhi, 2017; Etienne, Hossain, Redfield, Stafford, & 
Amoroso, 2010; Mayston, Kinyanda, Chishinga, Prince, & Patel, 2012; Nakimuli-Mpungu et al., 2012). 
Psychological interventions may work through providing support; the acquisition of new problem-
solving skills to deal with other life problems, and a reduction in time available to drinking through 
the development of a structured life (usually absent in PLWH dually diagnosed with unhealthy alcohol 
use within a trans-diagnostic model) (Rodriguez-Seijas, Arfer, Thompson, Hasin, & Eaton, 2017). 
Psychosocial interventions may address stigma, depression and anxiety that are faced by 
PLWH (Chung & Magraw, 1992; Edelman et al., 2017). The collation of evidence for effectiveness of 
various psychological therapies may help providers select the most suitable therapy to fit individual 
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patients’ circumstances. There are insufficient data on the effectiveness of interventions, the active 
ingredients of each treatment, the required dosing, and the circumstances under which they work 
(Brown et al., 2013). Brown et al (2013) called for efficacious interventions to be developed and 
implemented. This systematic review synthesizes current evidence on the effectiveness of various 
psychological interventions for unhealthy alcohol use in PLWH. 
Objectives 
To systematically synthesise evidence on the effectiveness of psychological interventions for 
unhealthy alcohol use on alcohol consumption and HIV treatment outcomes in people living with 
HIV/AIDS. 
Methods 
The protocol of this review was registered with PROSPERO (CRD42017063856). The review is 
reported using PRISMA guidelines. 
Electronic searches  
The following keywords were used in the search of the literature: 
(((HIV [Title/Abstract] OR AIDS [Title/Abstract] OR “human immunodeficiency virus” 
[Title/Abstract] OR “acquired immunodeficiency syndrome” [Title/Abstract] OR “retroviral infection” 
[Title/Abstract])) OR (HIV OR "Acquired Immunodeficiency Syndrome" [MeSH Terms]))) AND 
(((Alcohol*[Title/Abstract] OR drinking [Title/Abstract])) OR "Alcohol-Induced Disorders" OR 
"Alcohol-Related Disorders" OR "Alcohol Drinking" [MeSH Terms]))) AND ((“Psychological 
intervention” [Title/Abstract] OR therapy[Title/Abstract] OR psychotherapy [Title/Abstract] OR 
“motivational interview”[Title/Abstract] OR “motivational interviewing” [Title/Abstract] OR 
“contingency management” [Title/Abstract] OR “mutual help”[Title/Abstract] OR “twelve step 
facilitation” [Title/Abstract] OR “twelve steps” [Title/Abstract] OR “twelve step”[Title/Abstract]))) 
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Two reviewers searched, the Cochrane Central Register of Trials (CENTRAL), MEDLINE (Ovid) 
(1986-2017; EMBASE (EMBASE.com 1986-present); PsychInfo (Ovid)(1986-present), Clinical trials.gov 
(clinicaltrials.gov/). There were no language restrictions imposed on the search. 
Other search sources  
A search of the reference list and bibliographic references of the articles selected for inclusion 
in the review identified additional relevant articles. These were considered for data collection based 
on their titles and abstracts. Other searches were done through a hand search of authors who have 
published in the area. Authors whose publications were registered in the trial registers but 
unavailable in databases were contacted by email. 
Criteria for considering studies for this review 
Types of studies 
The full text of articles of studies that met the inclusion criteria were obtained for data 
synthesis. Studies included in the review were randomised controlled trials and other designs that 
used a quasi-random allocation mechanism, such as alternating assignment, next available treatment 
slot or wait-list controls. 
Types of participants 
Participants were PLWH aged 16 years and above who had unhealthy alcohol use with or 
without other substance use and were on antiretroviral therapy at hospitals, in clinics, and in the 
community. 
Types of intervention 
The interventions in the review articles included motivational interviewing, motivational 
enhancement therapy, cognitive behavioural therapy, community contingency therapy, group 
therapy or any combinations of the above that target unhealthy alcohol use with or without other 
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substance use. Control conditions included adherence counselling and referral to psychiatric units 
and usual care. 
Types of outcome measures 
1. Primary outcomes which were reduction in alcohol use as measured by the reduction in the 
frequency of alcohol consumption. 
2. Secondary outcomes which were other substance use, viral load, CD4 count change, quality 
of life and adherence to antiretroviral treatment. 
Data collection and analysis  
Selection of studies 
Two reviewers (MM and JJ) independently screened titles, abstracts, and then full texts to 
select studies that met all inclusion criteria including randomised controlled trials and other designs 
that used a quasi-random allocation mechanism, such as alternating assignment, next available 
treatment slot or wait-list controls. The review authors reconciled any differences through discussion 
at each stage. 
Data extraction and management 
Two reviewers (MM and AM) extracted data independently using a pre-piloted standardised 
data extraction form developed and piloted for this review. In the event of disagreements, the 
reviewers went through the original articles until they reached consensus. For each study included, 
we extracted the following information: (1) general (e.g. ethics approval, funding and study period); 
(2) methods (e.g. study design and number of participants randomised per group); (3) participants 
(e.g. country, setting, age and co-morbidity); interventions (e.g. type and duration of psychological 
intervention); (4) outcomes (e.g. description and time point collected); (5) results (e.g. numerical 
results for pre-specified outcomes); (6) comparisons (e.g. motivational interviewing versus treatment 
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as usual), and (7) risk of bias information (e.g. sequence generation, allocation concealment, and so 
on). 
Assessment of risk of bias in included studies 
Two reviewers (MM and AM) independently assessed the risk of bias of the included studies. 
A Cochrane Risk of Bias tool was used to assess bias in the included studies (Higgins et al., 2011). 
Domains assessed in the risk of bias assessment included adequacy of sequence generation and 
allocation concealment with respect to selection bias and blinding of the participants, research staff, 
and outcome assessors as related to detection bias. The other domains assessed were 
incomplete/missing outcome data caused by attrition or loss to follow up. Selective reporting was 
also assessed (i.e. where unfavourable or negative outcomes are not reported), and finally other bias 
including the influence of funders and other ethical considerations. 
Measures of treatment effect 
For binary outcomes, we calculated the risk ratio (RR) with its corresponding 95% confidence 
intervals (CI) where raw data were reported, otherwise we reported the odds ratios (OR) as reported 
by the study authors. For continuous data, we calculated the mean difference (MD) with its 
corresponding 95% CI. Both RR and MD were calculated using Review Manager 5.3 software (Review 
Manager (RevMan) [Computer program] Version 5.3. Copenhagen: The Nordic Cochrane Centre). 
Results  
Description of studies 
Results of the search  
A combined total of 7296 studies were identified through the various search methods and, 
after removing duplicates, screening titles and abstracts, 21 studies were retained. Full texts of the 
21 studies were retrieved and 14 studies which met the inclusion criteria were ultimately included in 
the review. The PRISMA diagram (Figure 1) summarises the results of the search. 
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Figure 1: PRISMA Diagram  
Characteristics of studies included 
The PRISMA diagram (Figure 1) summarises the results of the search. We included 14 studies 
that assessed alcohol use in PLWH. All 14 studies were randomised controlled trials. Eight studies 
included both men and women (Gilbert et al., 2008; Hasin et al., 2013; Meade et al., 2010; Papas et 
al., 2011; Parsons, Golub, Rosof, & Holder, 2007; Samet et al., 2005; Wong et al., 2008), one study 
included men who have sex with men only (Velasquez et al., 2009) and three studies included women 
only (Rotheram-Borus et al., 2012; Weiss et al., 2011; Zule et al., 2014). Three studies were from 
Africa (Papas et al., 2011; Wandera et al., 2017; Zule et al., 2014) while the rest were from the USA 
(Gilbert et al., 2008; Hasin et al., 2013; Meade et al., 2010; Naar-King et al., 2008; Parsons et al., 2007; 
Rotheram-Borus et al., 2012; Samet et al., 2005; Velasquez et al., 2009; Weiss et al., 2011; Wong et 
al., 2008). Six studies employed various forms of motivational interviewing (Gilbert et al., 2008; Hasin 
et al., 2013; Naar-King et al., 2008; Parsons et al., 2007; Samet et al., 2005; Velasquez et al., 2009) 
and two used cognitive behavioural therapy (Meade et al., 2010; Papas et al., 2011; Parsons et al., 
2007; Weiss et al., 2011). Two studies evaluated motivational therapies with the addition of 
technology (Gilbert et al., 2008; Hasin et al., 2013). Eight studies (Chander, Hutton, Lau, Xu, & McCaul, 
2015; Hasin et al., 2013; Meade et al., 2010; Naar-King et al., 2008; Papas et al., 2011; Parsons et al., 
2007; Samet et al., 2005; Wandera et al., 2017; Wong et al., 2008) delivered individual interventions 
while three delivered group therapies (Rotheram-Borus et al., 2012; Velasquez et al., 2009; Weiss et 
al., 2011). A wide range of alcohol use measures were administered across the studies, with the 
majority utilising self-report questionnaires. Table 1 gives a summary of included studies. 
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Excluded studies  
Seven studies out of 21 were excluded from the review. Three were excluded because they 
were not randomised (Moore et al., 2015; Peltzer, Tabane, Matseke, & Simbayi, 2010); and one 
excluded because it was a sub-analysis of an included study (Aharonovich et al., 2017). Three (Huis n 
‘t Veld  et al 2012, Parry et al 2014 and Madhombiro et al 2017) studies were excluded because they 
were ongoing studies. 
Risk of bias in studies included 
The results of the risk of bias assessment are summarized in Figures 2 and 3. Below we briefly 
report the results. 
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Figure 2: The risk of bias assessment of the 14 studies included in our review. Most studies were at 
high or unclear risk of performance, detection and attrition biases. 
 
Figure 3: Presentation of assessment of bias findings in the included studies, with most studies 
being free of selective reporting and other biases. 
Allocation (selection bias)  
Ten studies (Chander et al., 2015), (Gilbert et al., 2008; Hasin et al., 2013; Naar-King et al., 
2008; Parsons et al., 2007; Rotheram-Borus et al., 2012; Velasquez et al., 2009; Wandera et al., 2017; 
Wong et al., 2008; Zule et al., 2014) were judged to be at low risk of bias for sequence generation as 
they used computers to assign participants to the allocated treatment arms. Three studies (Gilbert et 
al., 2008; Wong et al., 2008; Zule et al., 2014) had allocation procedures that were unclear or at high 
risk of allocation concealment bias either because the participants would have known the arms they 
were allocated to or the approach to concealment such as use of an opaque envelope was not 
defined. The Papas et al (2011) study was judged to be at low risk of bias for allocation concealment 
and an unclear risk of bias for sequence generation. 
Blinding (performance bias and detection bias) 
Only a single study (Velasquez et al., 2009) was judged to be at low risk of performance 
detection bias as the assessors were blinded to the intervention. Chander et al (2015)  was judged to 
be at low risk of detection bias, but the presence of performance bias was not clear. All the studies 
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were either at high or unclear risk of performance bias except Velasquez et al (2009) since they did 
not report on blinding or they stated that the assessors or participants were not blinded. Apart from 
Velasquez et al (2009) and Chander et al (2015) all the studies were at high or unclear risk of detection 
bias as they did not report on how the outcome assessors were blinded.   
Incomplete outcome data (attrition bias) 
While seven studies (Chander et al., 2015; Gilbert et al., 2008; Hasin et al., 2013; Naar-King et 
al., 2008; Papas et al., 2011; Rotheram-Borus et al., 2012; Wandera et al., 2017) were judged to be at 
low risk of attrition bias, five studies (Meade et al., 2010; Samet et al., 2005; Velasquez et al., 2009; 
Wong et al., 2008; Zule et al., 2014) were at high risk of attrition bias (loss to follow-up) and for two 
studies (Parsons et al., 2007; Weiss et al., 2011) it was unclear whether there was attrition bias. The 
studies that were at high risk of incomplete outcome data had high rates of loss to follow-up.  
Selective reporting (reporting bias)  
All the studies were judged to be at low risk of selective reporting in this review because they 
all reported on the outcomes they intended to assess. 
Other potential sources of bias 
None of the studies was judged to be at high risk of other biases as they clearly addressed 
other issues such as the funding, ethical considerations and they declared authors’ interests. 
Effects of interventions  
The included studies can be classified according to the following five comparisons: (1) 
Motivational Interviewing (MI) versus Control; (2) Cognitive-Behavioural Therapy (CBT) versus 
Training as Usual (TAU); (3) Brief Intervention (BI) versus TAU; (4) Computer/ Technology versus TAU; 
and (5) Group therapy versus TAU/Wait List/Nutritional. 
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We analysed data separately for each of these comparisons due to the lack of homogeneity. 
i. Comparison 1: Motivational Interviewing (MI) versus Control 
Five studies assessed this comparison (Hasin et al., 2013; Naar-King et al., 2008; Parsons et al., 
2007; Samet et al., 2005; Velasquez et al., 2009). 
Primary outcome 
Reduction in alcohol use 
All five studies measured this outcome. A study involving both females and males with three-
parallel groups intervention study (Hasin et al., 2013) measured the number of drinking days over a 
60-day period and found no significant difference between the two treatment groups (mean 
difference [MD] -0.71 days, 95%CI: -1.73 to 0.11, n=170). 
A women-only intervention (Naar-King et al., 2008) measured most standard drinks in one 
week and also found no significant difference in the log-transformed 6-month follow-up change 
scores between the two treatment groups (MD -0.36, 95%CI: -0.84 to 0.12, n=49). 
A predominantly male study (Parsons et al., 2007) measured the number of drinks per drinking 
day from baseline to 3 months and from baseline to 6 months; however, since the authors did not 
report the standard deviations, we could not calculate the treatment effect. The authors reported no 
significant difference between the two treatment groups. 
A two-arm study (Samet et al., 2005) measured the number of drinks per day at baseline and 
short- and long- term follow-up. There were no significant differences between the two treatment 
groups at both short-term (MD -0.10, 95%CI: -1.48 to 1.68, n=117) and long-term follow-up (MD 0.40, 
95%CI: -1.25 to 2.05, n=97). 
A men sex with men (MSM) population study (Velasquez et al., 2009) measured the number 
of drinks per 30-day period. Participants in the control group drank significantly more alcohol 
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compared to the motivational interviewing group (OR 1.38, 95%CI: 1.02 to 1.86), according to the 
study authors. However, the study did not report the actual number of participants experiencing the 
event per treatment group and therefore we could not calculate the risk ratio. 
Secondary outcomes 
Reduction in viral load 
Three studies assessed viral loads. One of the studies (Velasquez et al., 2009) measured the 
decrease in log viral load from baseline to 6 months and there was no significant difference between 
motivational interviewing and control groups (MD -1.23, 95%CI: -2.48 to 0.03, n=46). 
Another US based study (Samet et al., 2005) measured log viral load at baseline, 3 months, 
and 6 months. The motivational interviewing group was significantly more likely to reach a 0.5 log 
viral load reduction (risk ratio [RR] 2.03, 95%CI: 1.11 to 3.70, n=117) and 1.0 log viral load reduction 
(RR 2.16, 95%CI: 1.02 to 4.58, n=117) at 3 months than the control group. However, there were no 
significant differences between the two treatment groups at 6 months. 
Samet et al (2005) measured log viral load at baseline, short-term and long-term. There were 
no significant differences between the two treatment groups at both short-term (MD -0.40, 95%CI: -
1.03 to 0.23, n=113) and long-term (MD 0.20, 95%CI: -0.49 to 0.89, n=93). 
CD4 count 
Two studies measured CD4 count (Parsons et al., 2007; Samet et al., 2005). One of the studies 
(Parsons et al., 2007) measured CD4 count at baseline, 3 months, and 6 months. The motivational 
interviewing group was significantly more likely to reach a 10% increase in CD4 count (RR 2.60, 95%CI: 
1.20 to 5.65, n=117) at 3 months than the control group. However, there were no significant 
differences between the two treatment groups at 6 months. 
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The other study (Samet et al., 2005) measured CD4 count at baseline, short term and long-
term. CD4 count was significantly higher in the motivational interviewing group compared to the 
control group at both short-term (MD 105, 95%CI: 10.03 to 199.97, n=113) and long-term (MD 150, 
95%CI: 32.89 to 267.11, n=94). 
ART adherence 
Two studies assessed ART adherence (Parsons et al., 2007; Samet et al., 2005). One of the two 
studies (Parsons et al., 2007) measured ART adherence in terms of both percent dose adherence and 
percent day adherence from baseline to 3 months and also from baseline to 6 months. At 3 months, 
the motivational interviewing group was significantly more likely to adhere in terms of dose 
adherence than the control group (MD 10.30%, 95%CI: 0.82 to 19.78%, n=121). However, there were 
no significant differences between the two treatment groups at 6 months (MD 5.30%, 95%CI: -7.41 
to 18.01%, n=115). At 3 months, the motivational interviewing group was significantly more likely to 
adhere in terms of day adherence than the control group (MD 10.70%, 95%CI: 2.58 to 18.82%, n=121). 
However, there were no significant differences between the two treatment groups at 6 months (MD 
8.90%, 95%CI: -3.34 to 21.14%, n=115). 
The other study (Samet et al., 2005) measured 30-day adherence at baseline, short-term and 
long-term. There was no significant difference in adherence between the two treatment groups at 
both short-term (MD 0.04, 95%CI: -0.05 to 0.13, n=138) and long-term (MD 0.00, 95%CI: -0.06 to 0.06, 
n=94). 
Reduction in HIV risky behaviour 
Two studies assessed the comparison to measure HIV risky behaviour. Naar-King et al., (2008) 
measured the number of unprotected sex acts but there was no significant difference in the log-
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transformed 6-month follow-up change scores between the two treatment groups (MD 0.09, 95%CI: 
-0.54 to 0.72, n=48). 
The other study (Velasquez et al., 2009) measured the number of days of unprotected sex per 
30-day period. Although there were significant reductions in this outcome over time in each of the 
treatment groups, there were no significant differences between the two groups, as reported by 
study authors (p=0.933). We could not calculate the risk ratio since the actual number of participants 
experiencing the event per intervention group was not given. 
Other substance use 
One study (Naar-King et al., 2008) assessing this comparison measured the maximum number 
of times marijuana was used in one week and there was no significant difference in the log-
transformed 6-month follow-up change scores between the two treatment groups (p=0.28), as 
reported by study authors. We could not calculate the treatment effect because the authors 
erroneously reported the same mean (SD) in both groups. 
ii. Comparison 2: Cognitive-Behavioural Therapy (CBT) versus Control 
One study (Papas et al., 2011) assessed this comparison. 
Primary outcome 
Reduction in alcohol use 
Papas et al., (2011) measured the percent of drinking days and the number of drinks per 
drinking day. At 30-days post-treatment, there were significantly larger reductions from baseline in 
both percent of drinking days (MD -24.93%, 95%CI: -37.44 to -12.42%, n=70) and number of drinks 
per drinking day (MD -2.88 drinks, 95%CI: -4.58 to -1.18 days, n=70), compared to the control group. 
Similar results were obtained during the next 30 days (from 30-days to 60-days) in both percent of 
drinking days (MD -21.87%, 95%CI: -34.97 to -8.77%, n=70) and number of drinks per drinking day 
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(MD -3.50 drinks, 95%CI: -5.55 to -1.45 days, n=70), compared to the control group. From 60-days to 
90-days, the CBT group still experienced significantly greater reductions in both percent of drinking 
days (MD -16.92%, 95%CI: -30.46 to -3.38%, n=68) and number of drinks per drinking day (MD -2.51 
drinks, 95%CI: -4.57 to -0.45 days, n=68), compared to the control group. 
Secondary outcomes 
The study Papas et al (2011) did not assesses any secondary outcomes. 
iii. Comparison 3: Brief intervention (BI) versus Treatment as usual (TAU) 
Three studies assessed this comparison. 
Reduction in the frequency of alcohol use 
All the three studies (Chander et al., 2015; Wandera et al., 2017; Wong et al., 2008) measured 
the frequency of alcohol use. One study (Chander et al., 2015) measured 90-day drinking frequency, 
frequency of heavy/binge drinking, and number of standard drinks per drinking day, among HIV 
positive women. At the 90-day follow-up, the brief intervention significantly reduced the probability 
of having a drinking day compared to treatment as usual (Odds Ratio [OR] 0.42, 95%CI: 0.23 to 0.75, 
p=0.0005, n=112). However, the brief intervention failed to reduce 90-day frequency of binge 
drinking (OR 0.60, 95%CI: 0.24 to 1.54, p=0.293, n=112) significantly and the 90-day number of drinks 
per drinking day (OR 0.92, 95%CI: 0.68 to 1.24, p=0.586, n=112). There were no raw data reported to 
calculate treatment effects. 
A Ugandan-based study (Wandera et al., 2017) measured alcohol consumption outcomes 
using the change in Alcohol Use Disorders Identification Tool (AUDIT-C) scores. The brief intervention 
significantly improved the AUDIT-C score at 3 months (MD 0.80, 95%CI: 0.11 to 1.49, n=291), 
compared to counselling. However, there was no significant difference in AUDIT-C score at 6 months 
between brief intervention and counselling groups (MD 0.50, 95%CI: -0.16 to 1.16, n=320). 
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Wong et al., (2008) measured the number of days using marijuana or alcohol but did not 
report separate results for alcohol. 
Secondary outcomes 
Reduction in viral load 
Only one study (Chander et al., 2015) measured viral suppression (HIV-1 RNA < 50). They 
reported no significant effect on viral suppression of a brief intervention compared to counselling in 
HIV positive women (OR 1.30, 95%CI: 0.65 to 2.61, n=148). We could not confirm the treatment effect 
because raw data were not reported. 
ART adherence 
The same study (Chander et al., 2015) measured antiretroviral adherence among HIV positive 
women but found that brief intervention failed to improve appointment adherence (defined as 
number of completed visits defined by total scheduled visits) (OR 1.11, 95%CI: 0.85 to 1.45, p=0.43, 
n=148) significantly, as reported by study authors. 
Reduction in HIV risky behaviour 
Chander et al., (2015) reported that a brief intervention significantly reduced the likelihood of 
having unprotected vaginal sex compared to the usual care group (adjusted odds ratio [aOR] 0.39, 
95%CI: 0.16 to 0.95, p=0.041, n=148), after adjusting for baseline number of days of unprotected sex, 
as reported by study authors. 
Other substance use 
Wong et al., (2008) measured the total number of days using drugs or alcohol. They found a 
significantly greater reduction over time in the brief intervention group with regards to 
alcohol/marijuana use (p<0.0001); drugs other than marijuana or alcohol (p<0.0001); and any 
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substance (p<0.0001), compared to the usual care group They also found a significantly greater 
reduction in the number of recent days of hard drug use (heroin, cocaine, crack, speedball, MDMA) 
in the brief intervention group compared to the usual care group (p<0.0001). 
iv. Comparison 4: Computer/ Technology versus Treatment as usual (TAU) 
Two studies assessed this comparison (Gilbert et al., 2008; Hasin et al., 2013). 
Primary outcome 
Reduction in alcohol use 
Both studies assessing this comparison measured the frequency of alcohol use. One study 
(Gilbert et al., 2008) compared an interactive patient-tailored computer program, Positive Choice, 
also referred to as "Video Doctor", with a control group that did not interact with “Video Doctor”. 
However, there was no significant difference between the two treatment groups in any risky drinking 
at both 3 months (RR 0.88, 95%CI: 0.63 to 1.22, n=150) and 6 months (RR 0.85, 95%CI: 0.61 to 1.19, 
n=154). The authors also reported no significant difference in binge drinking episodes and number of 
drinks per week, both at 3 months and at 6 months (data not shown). 
Hasin et al., (2013) compared MI + HealthCall technology versus Attention/Education control 
and found that the MI + HealthCall technology significantly reduced the number of drinking days 
during the 60-day period (MD -1.17 days, 95%CI: -1.95 to -0.39, n=172). 
Secondary outcomes 
Reduction in HIV risky behaviour 
Gilbert et al., (2008) found that the “Video Doctor” significantly reduced the number having 
any unprotected sex compared to the control group at both 3 months (RR 0.75, 95%CI: 0.62 to 0.90, 
n=218) and 6 months (RR 0.76, 95%CI: 0.63 to 0.93, n=194). 
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Other substance use 
Gilbert et al., (2008) reported that using “Video Doctor” was found to significantly reduce the 
number with any drug use compared to the control group at both 3 months (RR 0.77, 95%CI: 0.61 to 
0.97, n=149) and 6 months (RR 0.56, 95%CI: 0.43 to 0.72, n=158). 
v. Comparison 5: Group versus TAU/Wait list/ Nutritional 
Four studies assessed this comparison (Meade et al., 2010; Rotheram-Borus et al., 2012; Weiss 
et al., 2011; Zule et al., 2014). 
Primary outcome 
Reduction in alcohol use 
All four studies measured alcohol use. Meade et al., (2010) measured the reduction in the 
number of drinks per month from baseline to 12 months and found no significant difference between 
the intervention group compared to the support/ control group (MD 3.50, 95%CI: -1.98 to 8.98, 
n=247). 
A family-based intervention (Rotheram-Borus et al., 2012) assessed mothers living with HIV 
and their school-going adolescent children using a family-focused cognitive behavioural small group 
intervention. Among the mothers living with HIV who were using alcohol, those in the intervention 
unexpectedly drank more than those in the control group (p<0.01). Since raw data were not reported, 
we could not calculate the treatment effect. 
In their second study SWP II, Weiss et al., (2011) reported a significant reduction in alcohol 
use between baseline and 12 months in both treatment groups; however, no comparison between 
the treatment groups was provided and therefore we cannot make conclusions regarding treatment 
effect on alcohol use. 
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A South African study among women (Zule et al., 2014) measured the number who were 
abstinent from alcohol and compared this outcome between HIV infected women receiving Women's 
Health Coop (WHC) intervention and a comparison control group. At 12-month follow-up, abstinence 
from alcohol was significantly higher in the intervention compared to the control group (RR 2.57, 
95%CI: 1.20 to 5.50, n=84). 
Secondary outcomes 
Reduction in viral load 
In their second study SWP II, Weiss et al., (2011) reported a significant reduction in viral load 
in the intervention group (p<0.01) and not in the control group over 24 months among HIV positive 
women with detectable viral loads at baseline. However, no comparison between the treatment 
groups was given and therefore we cannot make any conclusion regarding treatment effects on viral 
load. 
ART adherence 
SWP II study (Weiss et al., 2011) reported that participants in the intervention group had 
significantly improved ARV adherence compared to the control group (p<0.05). 
Reduction in HIV risky behaviour 
SWP II study (Weiss et al., 2011) reported that the odds of having unprotected sex were 
significantly reduced in the intervention group compared to the control group (p<0.038). 
Other substance use 
SWP II study (Weiss et al., 2011) reported no change in drug use over time (data not shown). 
Quality of life 
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SWP II study (Weiss et al., 2011) reported significant improvement in mental health quality of 
life for the intervention group (p<0.05) and no increase in the control group. However, no 
comparisons were performed between the two groups and therefore we cannot make any conclusion 
regarding treatment effects on quality of life. 
Review of results 
This systematic review aimed to synthesize studies that have investigated the effectiveness of 
psychological interventions for problematic alcohol use in PLWH. We identified 14 studies that met 
our inclusion criteria. Owing to significant differences across studies in terms of the populations 
studied, the heterogeneity of the interventions, and differences in outcome measures, a meta-
analysis could not be performed. We aimed to investigate the effectiveness of psychological 
interventions for alcohol use in HIV infected populations. We also assessed a number of secondary 




For the primary outcome of frequency of alcohol use, five studies of motivational interviewing 
were used. However, only one study (Velasquez et al., 2009) found a significant difference: the 
motivational interviewing group significantly reduced the number of drinks per 30-day period 
compared to the control group. The other four studies (Hasin et al., 2013) (Naar-King et al., 2008; 
Parsons et al., 2007; Samet et al., 2005) found no significant difference in the frequency of alcohol 
use. We could not pool results from these five studies in a meta-analysis because outcomes were 
measured in different ways. Velasquez et al (2009) was judged to be at low risk of bias in all respects 
except significant loss to follow up. As a result, replication of this study and improvement in retention 
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is necessary. The other studies that used motivational interviewing had small sample sizes(Naar-King 
et al., 2008; Parsons et al., 2007; Samet et al., 2005). 
Cognitive-Behavioural Therapy (CBT) 
Papas et al (2011), a study with small sample size (n=75), assessed the effects of cognitive 
behavioural therapy on drinking. There were significantly larger reductions in both percent of drinking 
days and number of drinks per drinking day, compared to the control group, from baseline to 30, 60, 
and 90 days. Although this study showed a treatment effect it had a small sample. 
Brief intervention (BI) 
Three studies assessed the effects of brief interventions on frequency of alcohol use. ). Two 
studies (Chander et al., 2015) (Wandera et al., 2017) did not find significant effects on the frequency 
of alcohol use after 90-days. However, among HIV positive women, Chander et al (2015) found brief 
intervention significantly reducing the odds of having a drinking day compared to treatment as usual, 
only up to 90-day follow-up. In the Wandera et al (2017) study, a brief intervention significantly 
improved the AUDIT-C  score at 3 months, compared to alcohol counselling alone. AUDIT-C measures 
alcohol consumption and not frequency. In the two studies that demonstrated an effect, this effect 
was seen in women participants. Women have been shown to become more engaged in treatment 
in other studies and a recent systematic review on adherence treatment showed women to be at 
lower risk of non-adherence to treatment (Heestermans, Browne, Aitken, Vervoort, & Klipstein-
Grobusch, 2016). 
Computer/Technology 
Hasin et al (2013) found that the combination of MI and HealthCall technology significantly 
reduced the number of drinking days during a 60-day period. However, Gilbert et al (2008) found that 
the "Video Doctor" failed to reduce the frequency of alcohol use. This finding in a single study is 
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important. Mobile penetration has significantly improved world-wide including countries in Sub-
Saharan Africa which have a high burden of HIV with nearly half a billion persons with mobile 
connectivity (www.gsmaintelligence.com). Use of these platforms can help these countries improve 
HIV treatment adherence as delivery of these interventions may be cost effective (Forman et al., 
2018). Brown et al (2013) in their review and critique suggested the use of booster sessions to 
improve outcomes of psychosocial interventions, and the use of mobile technologies may be a 
solution. 
Group intervention 
Zule et al (2014), in a study among women in South Africa, found that abstinence from alcohol 
was significantly higher in the intervention group compared to the control group at 12-months follow-
up. Meade et al (2010) measured the reduction in the number of drinks per month from baseline to 
12 months and found no significant difference between the intervention and support/control groups. 
Rotheram-Borus et al (2011) found that among mothers living with HIV who were using alcohol, those 
in the intervention unexpectedly drank more than those in the control group. Zule at el (2014) was 
judged to be at significant high risk of bias or unclear results, while Rotheram-Borus (2011) was at 
low or unclear risk of bias. This suggests more work in development of this intervention which is 
deemed low cost. 
Secondary outcomes 
Reduction in viral load 
Out of the three studies that used motivational interviewing and measured viral load, one 
study Parsons et al (2007) found a significant group difference: the motivational interviewing group 
was significantly more likely to reach 0.5 and 1.0 log viral load reductions at 3 months, although there 
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was no significant group difference at 6 months. Chander et al (2015) who used a brief intervention 
did not show an improvement in viral load. 
CD4 
The two studies using motivational interviewing that reported on CD4 count found significant 
differences in favour of the motivational interviewing group. Meade et al (2010) using cognitive stress 
management found a greater odd of attaining a 10% increase in CD4 count at 3 months, compared 
to the control group. Samet et al (2005) found a significantly higher CD4 count in the motivational 
interviewing group compared to the control group, both in the short- and long- term. Although CD4 
has been replaced by viral load as the key measure for initiating HIV treatment and assessing 
treatment progress, it is still considered valuable in assessing all-cause mortality in HIV care (Ford, 
Meintjes, Vitoria, Greene, & Chiller, 2017). 
ART adherence 
Motivational interviewing was used in two studies that reported on ART adherence (Parsons 
et al., 2007; Samet et al., 2005). Parsons et al (2007) found that the motivational interviewing group 
was significantly more likely to adhere in terms of both percent dose adherence and percent day 
adherence from baseline to 3 months, compared to the control group. However, there were no 
significant differences in both outcomes from baseline to 6 months. Samet et al (2005) measured 30-
day adherence at baseline, short term and long-term; however, there was no significant difference in 
adherence between the two treatment groups at both short- and long-term follow-up. 
Weiss et al (2011) reported that the intervention significantly improved ARV (antiretroviral) 
adherence compared to the control group. However, they reported no change in drug use. 
Reduction in HIV risky behaviour  
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Two studies used motivational interviewing measured HIV risky behaviour. Naar-King et al 
(2008) found no significant difference in the number of unprotected sex acts between the two 
treatment groups Velasquez et al (2009) also found no significant difference in the number of days of 
unprotected sex per 30-day period. However, Gilbert et al (2008) found that the “Video Doctor” 
significantly reduced the number having any unprotected sex compared to the control group at both 
3 and 6 months. Reduction in new infections has become the latest target in the control of HIV. Use 
of Pre-Exposure Prophylaxis (PrEP) reduces the risk of infections, but in populations where this is not 
available, behavioural interventions that target risky behaviours and sexually transmitted infections 
control are essential. 
Other substance abuse 
Wong et al (2008) found that a brief intervention significantly reduced alcohol/ marijuana use 
and other drug use including hard drugs (heroin, cocaine, crack, and speedball, MDMA), compared to 
the usual care group. Gilbert et al (2008) also found that the “Video Doctor” significantly reduced the 
number with any drug use compared to the number in the control group at both 3 and 6 months. 
Despite the advent of harm reduction strategies such as needle exchange in injection drug users 
(Nishijima et al., 2013), HIV infections are still high in populations that engage in these practices 
(Young et al., 2017). HIV interventions therefore, need to include strategies to reduce substance 
abuse. 
Quality of life 
Only one study, (Weiss et al., 2011), assessed quality of life improvement. They found a group 
intervention effective in improving quality of life in PLWH. Quality of life should be a key outcome in 
HIV treatment programs as it directly relates to treatment engagement (Jong, Carrico, Cooper, 
Thompson, & Portillo, 2017; Logie, Kennedy, Tharao, Ahmed, & Loutfy, 2017). 
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Overview of results 
The studies that we identified in this review were diverse, included two or more active arms, 
and largely focused on motivational interviewing and cognitive behavioural therapies with boosters 
delivered through technological aids. The fact that only four studies had a significant effect and ten 
had no significant effect on alcohol use, calls for more research into developing interventions that 
are methodologically sound, easy to deliver, acceptable, time-saving and culturally appropriate. 
There are ongoing efforts to deliver interventions using technology platforms such as smartphone 
and computers (Gilbert et al., 2008; Hasin et al., 2013). These interventions, however, may require 
more capital outlay in the rollout but, once that is achieved, longer-term benefits may be realized. 
Another important challenge with interventions included in this review was the diversity of 
assessment tools used to assess alcohol use outcomes. While some studies measured the quantity of 
alcohol consumed, other studies assessed drinking frequency, and yet others used tools such as the 
AUDIT to measure a number of drinking parameters. Although in their narrative review, Brown et al 
(2013) (Brown et al., 2013) called for studies that directly target alcohol use, they also called for the 
inclusion of an assessment that directly measures alcohol use. 
This review sought to assess the effectiveness of psychological interventions on other 
behaviours that impact on HIV treatment. Some studies (Parsons et al., 2007) and (Weiss et al., 2011) 
assessed risky sexual behaviour while other studies (Samet et al., 2005) and (Parsons et al., 2007) 
assessed CD4 count, both which showed positive change over three months. This is important, as 
most studies demonstrated no effect on alcohol use frequency which is important as it has a direct 
effect on adherence to ART, STIs and HIV transmission (Morrison et al., 1998). Two studies 
demonstrated improvement in adherence (Parsons et al., 2007; Weiss et al., 2011). In light of these 
findings, it is important that more research be undertaken to develop interventions that improve 
these outcomes. 
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A number of limitations deserve mention. Most important is the lack of standardised 
measures of alcohol use outcomes, whether frequency or quantity. Biochemical measures of alcohol 
use, such as the phosphotidyl ethanol and ethyl glucuronide, are recommended, in addition to self-
report instruments. Given that the effects of alcohol on PLWH are not only related to effects on 
adherence, sexual risk, use of other substances and virological control, but are also associated with 
immunosuppressant and deleterious effects on the liver, these outcomes need to be included as 
treatment targets. Further, the studies in this review included participants with different levels of 
alcohol use which may dilute the effects of an intervention. More severe users, including those with 
dependence, may require different doses of an intervention and perhaps adjunctive pharmacological 
therapies. 
Potential biases in the review processes 
The search was comprehensive and encompassed electronic searches of key databases and a 
search of reference lists of included studies and relevant reviews for additional studies. It is unlikely 
that any studies were missed. To reduce the potential for bias, two review authors independently 
undertook the selection of studies, extraction of data, and assessment for the risk of bias. If we had 
chosen different comparisons, we may have potentially ended up with different conclusions; 
however, our choice of comparisons was based on sound theoretical knowledge. Furthermore, we 
could have obtained more data if we had contacted authors and requested additional data but it was 
not possible owing to time constraints. Finally, using GRADEpro to assess the quality of evidence 
would have given more robust results; however, the heterogeneity in outcomes made it difficult to 
tease out outcomes for inclusion in GRADEpro (https://gradepro.org/). 
To our knowledge, this is the fourth systematic review to assess the evidence for psychological 
interventions for problematic alcohol use in PLWH. Brown et al (2013) had similar concerns in a 
review pertaining to outcome measures and the variation in study methodologies. A review by Samet 
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et al (2010) found limited evidence for the effectiveness of behavioural interventions, a finding 
replicated in this review. However, a recent review by Scott-Sheldon et al (2017) found behavioural 
interventions to be effective in reducing alcohol consumption, risky sexual behaviour and viral loads 
in PLWH. However, the interventions reviewed had no effects on alcohol use frequency as we also 
found in our systematic review. 
Conclusions 
Our review of psychological interventions for problematic alcohol use in PLWH finds some 
evidence for the effectiveness of motivational interviewing, cognitive behavioural therapy and brief 
intervention in reducing alcohol use in people living with HIV. Use of mobile health technology 
modestly improved motivational interviewing effects on alcohol use outcomes. For the studies that 
assessed secondary outcomes, there were some effects of motivational interviewing on viral loads, 
use of other substances, risky sexual behaviours and adherence to ART. No quantitative synthesis was 
possible because of the heterogeneity in outcomes. In sum, there was an overall lack of evidence for 
the effectiveness of the psychological interventions on alcohol use. In terms of practice, there is 
insufficient evidence to recommend any particular treatment modality. 
It is important that well designed, adequately-powered, pragmatic randomised controlled 
trials in high burden communities that focus specifically on alcohol use in PLWH be conducted. These 
studies need to incorporate standardised measures of alcohol use to allow for comparability between 
studies. 
  




ART  Antiretroviral Treatment 
ARV  Antiretroviral 
AUDIT  Alcohol Use Disorders Identification Test 
AUDIT-C Alcohol Use Disorders Identification Test-Consumption   
AUDs  Alcohol Use Disorders 
BI  Brief Intervention  
CBT  Cognitive Behavioural Therapy 
HIV  Human Immunodeficiency Virus 
MI  Motivational Interviewing 
PLWH  People Living with HIV/AIDS 
TAU  Treatment as Usual 
STI  Sexually Transmitted Infections 
Declarations 
Ethics approval and consent to participate 
This is a systematic review and has no contact with human and other materials. 
Consent for publication 
All the authors have read and consent to the publication of this manuscript. 
Availability of data and material 
Additional materials to this manuscript are available 
Competing interests 
MM – has no interest to declare 
JJ-has no interest to declare 
AM- has no interest to declare 
Stellenbosch University  https://scholar.sun.ac.za
55 
 
AC- has no interest to declare 
MA-has no interest to declare 
SS-has no interest to declare 
Funding 
Internal sources  
This review was funded by the PERFECT Program of the University of Zimbabwe College of Health 
Sciences under a D43 grant to Prof James Hakim. 
External sources  
This review received technical support from Prof Taryn Young of the Centre for Evidence Based Health 
Care of the Stellenbosch University. 
Authors' contributions 
MM and SS conceived the idea and developed the initial protocol. AC and MA refined the topic and 
revised the protocol. MM and JJ carried out the electronic searches, screened the titles and searched 
for studies in reviews and other sources. MM and AM developed data extraction form, extracted the 
data and carried out the risk of bias assessments. AM performed all the data analyses, reported the 
results. MM and SS summarised the results in the discussion section.  All the authors revised the draft 
manuscript and provided essential revisions to the draft. 
Acknowledgements 
We are grateful to Mr. Masimba Muziringa for all the work during the development of the search 
strategy. We are also grateful to Prof James Hakim for providing valuable critique of the original 
concept. We are also grateful to Mr. Antony Matsika and the PERFECT team at the University of 
Zimbabwe for their logistic support.  
Stellenbosch University  https://scholar.sun.ac.za
56 
 
Chapter Two References 
Aharonovich, E., Hatzenbuehler, M. L., Johnston, B., O'Leary, A., Morgenstern, J., Wainberg, M. L., 
Hasin, D. S. (2006). A low-cost, sustainable intervention for drinking reduction in the HIV 
primary care setting. AIDS Care, 18(6), 561-568. doi:10.1080/09540120500264134 
Aharonovich, E., Stohl, M., Cannizzaro, D., & Hasin, D. (2017). HealthCall delivered via smartphone to 
reduce co-occurring drug and alcohol use in HIV-infected adults: A randomized pilot trial. J 
Subst Abuse Treat, 83, 15-26. doi:10.1016/j.jsat.2017.09.013 
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders : DSM-
5(5th ed.). Arlington, V. A. P. A.  
<AUD_Depression_Transdiagnostic_WHOSouth-EastAsiaJPublicHealth6150-4198152_113941.pdf>.  
Azar, M. M., Springer, S. A., Meyer, J. P., & Altice, F. L. (2010). A systematic review of the impact of 
alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and 
health care utilization. Drug Alcohol Depend, 112(3), 178-193. 
doi:10.1016/j.drugalcdep.2010.06.014 
Babor TF, D. l. F. J., Saunders JB, Grant M. AUDIT—the alcohol use, care., d. i. t. g. f. u. i. p. h., & 1989b., 
G. WHO.  
Balhara, Y. P. S., Gupta, P., & Elwadhi, D. (2017). Co-occurring depression and alcohol-use disorders 
in South-East Asia: A narrative review. WHO South East Asia J Public Health, 6(1), 50-59. 
doi:10.4103/2224-3151.206166 
Brown, J. L., DeMartini, K. S., Sales, J. M., Swartzendruber, A. L., & DiClemente, R. J. (2013). 
Interventions to reduce alcohol use among HIV-infected individuals: a review and critique of 
the literature. Curr HIV/AIDS Rep, 10(4), 356-370. doi:10.1007/s11904-013-0174-8 
Chander, G., Hutton, H. E., Lau, B., Xu, X., & McCaul, M. E. (2015). Brief intervention decreases 
drinking frequency in HIV-Infected, heavy drinking women: Results of a randomized 
Stellenbosch University  https://scholar.sun.ac.za
57 
 
controlled trial. J Acquir Immune Defic Syndr, 70(2), 137-145. 
doi:10.1097/QAI.0000000000000679 
Chung, J. Y., & Magraw, M. M. (1992). A group approach to psychosocial issues faced by HIV-positive 
women. Hosp Community Psychiatry, 43(9), 891-894.  
Edelman, E. J., Lunze, K., Cheng, D. M., Lioznov, D. A., Quinn, E., Gnatienko, N., Samet, J. H. (2017). 
HIV Stigma and substance use among HIV-Positive russians with risky drinking. AIDS Behav, 
21(9), 2618-2627. doi:10.1007/s10461-017-1832-4 
Etienne, M., Hossain, M., Redfield, R., Stafford, K., & Amoroso, A. (2010). Indicators of adherence to 
antiretroviral therapy treatment among HIV/AIDS patients in 5 African countries. J Int Assoc 
Physicians AIDS Care (Chic), 9(2), 98-103. doi:10.1177/1545109710361383 
Eyawo, O., McGinnis, K. A., Justice, A. C., Fiellin, D. A., Hahn, J. A., Williams, E. C.,. team, V. P. (2018). 
Alcohol and Mortality: Combining Self-Reported (AUDIT-C) and Biomarker Detected (PEth) 
Alcohol measures among HIV Infected and uninfected. J Acquir Immune Defic Syndr, 77(2), 
135-143. doi:10.1097/QAI.0000000000001588 
Ford, N., Meintjes, G., Vitoria, M., Greene, G., & Chiller, T. (2017). The evolving role of CD4 cell counts 
in HIV care. Curr Opin HIV AIDS, 12(2), 123-128. doi:10.1097/COH.0000000000000348 
Forman, L. S., Patts, G. J., Coleman, S. M., Blokhina, E., Lu, J., Yaroslavtseva, T., Chaisson, C. E. (2018). 
Use of an android phone application for automated text messages in international settings: 
A case study in an HIV clinical trial in St. Petersburg, Russia. Clin Trials, 15(1), 36-43. 
doi:10.1177/1740774517726067 
Galvan, F. H., Bing, E. G., Fleishman, J. A., London, A. S., Caetano, R., Burnam, M. A., Shapiro, M. 
(2002). The prevalence of alcohol consumption and heavy drinking among people with HIV 
in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol, 
63(2), 179-186.  
Stellenbosch University  https://scholar.sun.ac.za
58 
 
Gilbert, P., Ciccarone, D., Gansky, S. A., Bangsberg, D. R., Clanon, K., McPhee, S. J., Gerbert, B. (2008). 
Interactive "Video Doctor" counseling reduces drug and sexual risk behaviors among HIV-
positive patients in diverse outpatient settings. PLoS One, 3(4), e1988. 
doi:10.1371/journal.pone.0001988 
Gordon, S., Rotheram-Borus, M. J., Skeen, S., Perry, C., Bryant, K., & Tomlinson, M. (2017). Research 
priorities for the intersection of alcohol and HIV/AIDS in Low and Middle Income Countries: 
A priority setting exercise. AIDS Behav, 21(Suppl 2), 262-273. doi:10.1007/s10461-017-1921-
4 
Hasin, D. S., Aharonovich, E., O'Leary, A., Greenstein, E., Pavlicova, M., Arunajadai, S., Johnston, B. 
(2013). Reducing heavy drinking in HIV primary care: a randomized trial of brief intervention, 
with and without technological enhancement. Addiction, 108(7), 1230-1240. 
doi:10.1111/add.12127 
Heestermans, T., Browne, J. L., Aitken, S. C., Vervoort, S. C., & Klipstein-Grobusch, K. (2016). 
Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-
Saharan Africa: a systematic review. BMJ Glob Health, 1(4), e000125. doi:10.1136/bmjgh-
2016-000125 
Higgins, J. P., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Cochrane Statistical 
Methods, G. (2011). The Cochrane Collaboration's tool for assessing risk of bias in 
randomised trials. BMJ, 343, d5928. doi:10.1136/bmj.d5928 
https://gradepro.org/.  
Jong, S., Carrico, A., Cooper, B., Thompson, L., & Portillo, C. (2017). Engagement with health care 
providers as a mediator between social capital and quality of life among a sample of people 
living with HIV in the United States: Path-analysis. SSM Popul Health, 3, 448-454. 
doi:10.1016/j.ssmph.2017.05.001 
Stellenbosch University  https://scholar.sun.ac.za
59 
 
Le, K. B., Johnson, J. A., Seale, J. P., Woodall, H., Clark, D. C., Parish, D. C., & Miller, D. P. (2015). Primary 
care residents lack comfort and experience with alcohol screening and brief intervention: a 
multi-site survey. J Gen Intern Med, 30(6), 790-796. doi:10.1007/s11606-015-3184-y 
Lee, K. H., Olsen, J. B., & Sun, J. (2017). Emergency physician screening and management of trauma 
patients with alcohol involvement. J Emerg Trauma Shock, 10(4), 174-179. 
doi:10.4103/JETS.JETS_140_16 
Logie, C. H., Kennedy, V. L., Tharao, W., Ahmed, U., & Loutfy, M. R. (2017). Engagement in and 
continuity of HIV care among African and Caribbean Black women living with HIV in Ontario, 
Canada. Int J STD AIDS, 28(10), 969-974. doi:10.1177/0956462416683626 
Mayston, R., Kinyanda, E., Chishinga, N., Prince, M., & Patel, V. (2012). Mental disorder and the 
outcome of HIV/AIDS in low-income and middle-income countries: a systematic review. 
AIDS, 26 Suppl 2, S117-135. doi:10.1097/QAD.0b013e32835bde0f 
Meade, C. S., Drabkin, A. S., Hansen, N. B., Wilson, P. A., Kochman, A., & Sikkema, K. J. (2010). 
Reductions in alcohol and cocaine use following a group coping intervention for HIV-positive 
adults with childhood sexual abuse histories. Addiction, 105(11), 1942-1951. 
doi:10.1111/j.1360-0443.2010.03075.x 
Moore, B. A., Rosen, M. I., Wang, Y., Shen, J., Ablondi, K., Sullivan, A., Liu, H. (2015). A remotely-
delivered CBT and Contingency Management Therapy for substance using people with HIV. 
AIDS Behav, 19 Suppl 2, 156-162. doi:10.1007/s10461-014-0990-x 
Morrison, T. C., DiClemente, R. J., Wingood, G. M., & Collins, C. (1998). Frequency of alcohol use and 
its association with STD/HIV-related risk practices, attitudes and knowledge among an 
African-American community-recruited sample. Int J STD AIDS, 9(10), 608-612. 
doi:10.1258/0956462981921053 
Stellenbosch University  https://scholar.sun.ac.za
60 
 
Murray, E., Khadjesari, Z., Linke, S., Hunter, R., & Freemantle, N. (2013). Health on the web: 
randomised trial of work-based online screening and brief intervention for hazardous and 
harmful drinking. BMC Public Health, 13, 505. doi:10.1186/1471-2458-13-505 
Naar-King, S., Lam, P., Wang, B., Wright, K., Parsons, J. T., & Frey, M. A. (2008). Brief report: 
maintenance of effects of motivational enhancement therapy to improve risk behaviors and 
HIV-related Health in a randomized controlled trial of youth living with HIV. J Pediatr Psychol, 
33(4), 441-445. doi:10.1093/jpepsy/jsm087 
Nakimuli-Mpungu, E., Bass, J. K., Alexandre, P., Mills, E. J., Musisi, S., Ram, M., Nachega, J. B. (2012). 
Depression, alcohol use and adherence to antiretroviral therapy in sub-Saharan Africa: a 
systematic review. AIDS Behav, 16(8), 2101-2118. doi:10.1007/s10461-011-0087-8 
Nishijima, T., Gatanaga, H., Komatsu, H., Takano, M., Ogane, M., Ikeda, K., & Oka, S. (2013). High 
prevalence of illicit drug use in men who have sex with men with HIV-1 infection in Japan. 
PLoS One, 8(12), e81960. doi:10.1371/journal.pone.0081960 
Papas, R. K., Sidle, J. E., Gakinya, B. N., Baliddawa, J. B., Martino, S., Mwaniki, M. M., Maisto, S. A. 
(2011). Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use 
among human immunodeficiency virus-infected out-patients in western Kenya. Addiction, 
106(12), 2156-2166. doi:10.1111/j.1360-0443.2011.03518.x 
Parsons, J. T., Golub, S. A., Rosof, E., & Holder, C. (2007). Motivational interviewing and cognitive-
behavioral intervention to improve HIV medication adherence among hazardous drinkers: a 
randomized controlled trial. J Acquir Immune Defic Syndr, 46(4), 443-450.  
Peltzer, K., Tabane, C., Matseke, G., & Simbayi, L. (2010). Lay counsellor-based risk reduction 
intervention with HIV positive diagnosed patients at public HIV counselling and testing sites 
in Mpumalanga, South Africa. Eval Program Plann, 33(4), 379-385. 
doi:10.1016/j.evalprogplan.2010.03.002 
Stellenbosch University  https://scholar.sun.ac.za
61 
 
Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane 
Centre, T. C. C., 2014.  
Rodriguez-Seijas, C., Arfer, K. B., Thompson, R. G., Jr., Hasin, D. S., & Eaton, N. R. (2017). Sex-related 
substance use and the externalizing spectrum. Drug Alcohol Depend, 174, 39-46. 
doi:10.1016/j.drugalcdep.2017.01.008 
Rotheram-Borus, M. J., Rice, E., Comulada, W. S., Best, K., Elia, C., Peters, K., Valladares, E. (2012). 
Intervention outcomes among HIV-affected families over 18 months. AIDS Behav, 16(5), 
1265-1275. doi:10.1007/s10461-011-0075-z 
Samet, J. H., Horton, N. J., Meli, S., Dukes, K., Tripps, T., Sullivan, L., & Freedberg, K. A. (2005). A 
randomized controlled trial to enhance antiretroviral therapy adherence in patients with a 
history of alcohol problems. Antivir Ther, 10(1), 83-93.  
Samet, J. H., & Walley, A. Y. (2010). Interventions targeting HIV-infected risky drinkers: drops in the 
bottle. Alcohol Res Health, 33(3), 267-279.  
Scott-Sheldon, L. A. J., Carey, K. B., Johnson, B. T., Carey, M. P., & Team, M. R. (2017). Behavioral 
interventions targeting alcohol use among people living with HIV/AIDS: A systematic review 
and meta-analysis. AIDS Behav, 21(Suppl 2), 126-143. doi:10.1007/s10461-017-1886-3 
Strauss, S. M., Munoz-Plaza, C. E., Tiburcio, N. J., & Gwadz, M. (2012). Barriers and facilitators in 
implementing "prevention for positives" alcohol-reduction support: the perspectives of 
directors and providers in hospital-based HIV care centers. J Assoc Nurses AIDS Care, 23(1), 
30-40. doi:10.1016/j.jana.2011.03.001 
Van der Elst, E. M., Mbogua, J., Operario, D., Mutua, G., Kuo, C., Mugo, P., Sanders, E. J. (2013). High 
acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: 
qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations 
in Kenya. AIDS Behav, 17(6), 2162-2172. doi:10.1007/s10461-012-0317-8 
Stellenbosch University  https://scholar.sun.ac.za
62 
 
van Griensven, F., Thienkrua, W., Sukwicha, W., Wimonsate, W., Chaikummao, S., Varangrat, A., & 
Mock, P. A. (2010). Sex frequency and sex planning among men who have sex with men in 
Bangkok, Thailand: implications for pre- and post-exposure prophylaxis against HIV infection. 
J Int AIDS Soc, 13, 13. doi:10.1186/1758-2652-13-13 
VAPA., A. P. A. D. a. s. m. o. m. d. D.-T. A.  
Velasquez, M. M., von Sternberg, K., Johnson, D. H., Green, C., Carbonari, J. P., & Parsons, J. T. (2009). 
Reducing sexual risk behaviors and alcohol use among HIV-positive men who have sex with 
men: a randomized clinical trial. J Consult Clin Psychol, 77(4), 657-667. 
doi:10.1037/a0015519 
Wandera, B., Tumwesigye, N. M., Nankabirwa, J. I., Mafigiri, D. K., Parkes-Ratanshi, R. M., Kapiga, S., 
Sethi, A. K. (2017). Efficacy of a single, brief alcohol reduction intervention among men and 
women living with HIV/AIDS and using alcohol in Kampala, Uganda: A Randomized Trial. J Int 
Assoc Provid AIDS Care, 16(3), 276-285. doi:10.1177/2325957416649669 
Weiss, S. M., Tobin, J. N., Antoni, M., Ironson, G., Ishii, M., Vaughn, A., Team*, S. E. W. s. P. (2011). 
Enhancing the health of women living with HIV: the SMART/EST Women's Project. Int J 
Womens Health, 3, 63-77. doi:10.2147/IJWH.S5947 
Williams, E. C., Hahn, J. A., Saitz, R., Bryant, K., Lira, M. C., & Samet, J. H. (2016). Alcohol Use and 
Human Immunodeficiency Virus (HIV) Infection: Current knowledge, implications, and future 
directions. Alcohol Clin Exp Res, 40(10), 2056-2072. doi:10.1111/acer.13204 
Wong, F. L., Rotheram-Borus, M. J., Lightfoot, M., Pequegnat, W., Comulada, W. S., Cumberland, W., 
Healthy Living Trial, G. (2008). Effects of behavioral intervention on substance use among 
people living with HIV: the Healthy Living Project randomized controlled study. Addiction, 
103(7), 1206-1214. doi:10.1111/j.1360-0443.2008.02222.x 
www.gsmaintelligence.com.  
Stellenbosch University  https://scholar.sun.ac.za
63 
 
Young, J., Rossi, C., Gill, J., Walmsley, S., Cooper, C., Cox, J., Canadian Co-infection Cohort, I. (2017). 
Risk factors for Hepatitis C Virus reinfection after sustained virologic response in patients 
coinfected With HIV. Clin Infect Dis, 64(9), 1154-1162. doi:10.1093/cid/cix126 
Zule, W., Myers, B., Carney, T., Novak, S. P., McCormick, K., & Wechsberg, W. M. (2014). Alcohol and 
drug use outcomes among vulnerable women living with HIV: results from the Western Cape 
Women's Health CoOp. AIDS Care, 26(12), 1494-1499. doi:10.1080/09540121.2014.933769 
  
Stellenbosch University  https://scholar.sun.ac.za
64 
 
CHAPTER THREE:  


























































































 PILOT AND FEASIBILITY STUDY 
Title: Intervention for alcohol use disorders at an HIV care clinic in 
Harare: a pilot and feasibility study 
Authors 
Munyaradzi Madhombiro- Department of Psychiatry, Parirenyatwa Group of Hospitals, College of 
Health Sciences, Avondale, Zimbabwe 2) Harare Central Hospital, Psychiatric Unit, Southerton, 
Zimbabwe mmadhombiro@gmail.com  
Bazondlile Dube- Department of Psychiatry, Parirenyatwa Group of Hospitals, College of Health 
Sciences, Avondale, Zimbabwe bazoedube@gmail.com   
Michelle Dube- Department of Psychiatry, Parirenyatwa Group of Hospitals, College of Health 
Sciences, Avondale, Zimbabwe mmukonoweshuro@gmail.com   
Moleen Zunza-Stellenbosch University, Faculty of Medicine and Health sciences, Biostatistics Unit 
Cape Town South Africa moleenz@sun.ac.za  
Dixon Chibanda- Department of Psychiatry, Parirenyatwa Group of Hospitals, College of Health 
Sciences, Avondale, Zimbabwe 2) Harare Central Hospital, Psychiatric Unit, Southerton, Zimbabwe 
dichi@zol.co.zw  
Simbarashe Rusakaniko- Department of community medicine, Parirenyatwa Group of Hospitals, 
College of Health Sciences, Avondale, Zimbabwe srusakaniko@gmail.com  
Soraya Seedat Department of Psychiatry Stellenbosch University, Faculty of Medicine and Health 
sciences, Cape Town, South Africa sseedat@sun.ac.za  
Stellenbosch University  https://scholar.sun.ac.za
76 
 






Alcohol use in HIV infected patients is associated with risky sexual behaviour, poor adherence 
to Highly Active Antiretroviral Therapy (HAART), treatment failure and increased physiologic harm. 
An intervention for HIV infected patients with problematic alcohol use, developed through 
adaptation of existing evidence based psychological treatments, was assessed for its feasibility at a 
tertiary HIV care clinic in Zimbabwe. Registered general nurses, using a manualised protocol, 
delivered the intervention. Forty patients were recruited and randomised to receive either an MI/CBT 
intervention or the WHO mhGAP Intervention Guide for AUDs (n=20 patients per group). 
Women who scored 6 or more on the Alcohol Use Disorders Identification Test (AUDIT) and 
men who scored 7 or more on the AUDIT were eligible. Dementia and other mental disorders, age 
less than 18 years, and inability to commit to follow-up for 3 months were disqualifications. Patients 
who were on treatment for drug related problems were also ineligible. 
The objectives of the study were to pilot the outcome assessments to be used in the trial 
proper, assess the feasibility of delivery of a brief MI/CBT intervention compared to an WHO mhGAP 
intervention for problematic alcohol use in PLWH in Zimbabwe, and pilot the effectiveness (on alcohol 
use, functionality and CD4 count) of these interventions at 3 months in a randomised controlled trial 
design. 
Out of 40 participants enrolled, 31 were successfully followed up for three months with a loss 
to follow-up rate of 23%. There was a statistically significant decrease in AUDIT score over time in 
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both groups (p <0.00), however no statistically significant group difference with a mean difference of 
0.80, standard error of 2.07 and p value of 0.70. For the CD4 count, the median and interquartile 
ranges at baseline for MI/CBT and WHO mhGAP IG groups were 218(274) and 484(211.50), 
respectively. At follow-up, median and interquartile ranges for the CD4 count for MI/CBT and WHO 
mhGAP IG groups were 390(280) and 567(378), respectively, indicative of improvement in 
immunological parameters in both arms. Although the rate of loss to follow-up was 23%, this pilot 
study suggests that a brief MI/CBT delivered by Registered General Nurses for problematic alcohol 
use is feasible in this population but will require the implementation of additional measures to 
improve retention. 
Key words: Alcohol; HIV; MI/CBT Intervention; Psychological; Task sharing; Zimbabwe 
Trial registration:  Pan African Clinical Trial Registry, current PACTR201509001211149.  




Alcohol and illicit drug use can interfere with the success of HIV treatment programs and 
should be specifically targeted at patients in HIV care settings(Teixeira, Dourado Mde, Santos, & 
Brites, 2013). A US study found that alcohol use in HIV positive individuals was associated with higher 
rates of medical complications and poorer HIV treatment outcomes, including reduced viral load 
suppression (Braithwaite & Bryant, 2010). Studies have shown that people living with HIV (PLWH) 
drink twice as much as the general population, with increased mortality and physiological injury 
occurring at relatively low levels of alcohol use(Galvan et al., 2002). Studies from Nigeria, Brazil and 
Ethiopia have documented prevalence rates of problematic alcohol use in PLWH in the range of 14% 
to 32%(da Silva, Mendoza-Sassi, da Mota, Nader, & de Martinez, 2017; Egbe et al., 2017; Soboka, 
Tesfaye, Feyissa, & Hanlon, 2014). There is no data on problematic alcohol use in HIV infected persons 
in Zimbabwe Although the burden of disease is high with 1.6 million Zimbabweans living with HIV and 
800 000 on antiretroviral treatment (Council, 2016). With this burden of HIV and with high levels of 
alcohol intake, a significant proportion of the population may have problematic alcohol use requiring 
intervention that is culturally acceptable. 
A systematic review for determinants of adherence to HAART found alcohol use to be an 
obstacle to adherence(Heestermans, Browne, Aitken, Vervoort, & Klipstein-Grobusch, 2016). Alcohol 
use is associated with Hepatitis B and C co-infection and in PLWH liver malfunction may affect the 
metabolism of antiretroviral drugs(Puoti, Moioli, Travi, & Rossotti, 2012). Aside from the problems of 
non-adherence in PLWH, poor treatment outcomes may result from the physiological effects of 
alcohol. There is evidence that interventions for alcohol use can lead to the reduction in alcohol 
consumption in the general population(R. S. Braithwaite & Bryant, 2010). Studies have also shown 
that psychological interventions in PLWH can improve medication adherence even when these 
interventions have no effect on alcohol use (Samet et al., 2005; Wandera et al., 2017). Motivational 
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interviewing, cognitive behaviour therapy, problem solving techniques, contingency management 
and twelve-step facilitation are some of the psychological interventions that have evidence of 
effectiveness(Brown, DeMartini, Sales, Swartzendruber, & DiClemente, 2013). 
In developed countries where, highly trained specialists usually deliver psychological 
therapies, it has been shown that they can lead to a change in drinking behaviour. There have only 
been a few studies in low resource settings (Patel et al., 2007). A Kenyan study by Papas et al. (2011), 
using an adapted cognitive behavioural therapy intervention, showed improvement in alcohol use 
outcomes in HIV infected individuals(Papas et al., 2011). Another study from Uganda found that 
counselling and motivational interviewing, had more beneficial effects in women than in men with 
hazardous alcohol use(Wandera et al., 2017). Another study undertaken in South Africa that utilised 
group therapy also documented a reduction in the amount of alcohol consumed by drinking 
participants (Zule et al., 2014). A qualitative study to explore the acceptability of an alcohol use 
intervention by Morojele et al. (2014) found that participants were willing to engage in an alcohol-
focused motivational interviewing treatment (Kekwaletswe & Morojele, 2014). 
Although motivational interviewing is effective in motivating individuals to reduce alcohol 
consumption, its effects have been shown to fade over time and booster sessions have been 
recommended (Parsons, Golub, Rosof, & Holder, 2007). Further, some studies have combined 
motivational interviewing with cognitive behavioural therapy in participants with comorbidities, 
such as depression and anxiety(Riper et al., 2014). Zimbabwe has commenced rollout of the WHO 
mh-GAP IG for mental health interventions 
(https://www.msf.org.za/system/.../newsletter_msf_zimbabwe_issue1_2017.pdf?...) This has 
followed a call by the WHO for wide dissemination of the WHO mh GAP IG in an endeavour to close 
the treatment gap for mental, neurological and substance use disorders. Moreover, Counselling for 
Alcohol Problems (CAP), a large study in India used WHO mh-GAP IG as a comparison in their 
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mental health trials(Nadkarni, Weiss, et al., 2017). Use of the WHO mh-GAP IG in PLWH with 
problematic alcohol use, if shown to be effective, can further reduce the treatment gap for mental 
disorder comorbidities in this vulnerable population. 
While these studies have demonstrated benefits, larger sample studies are required (Papas et 
al., 2011; Wandera et al., 2017).  Further, variation in selection criteria and in the type of interventions 
across studies makes comparability challenging (Edelman et al., 2016). For example, patients with 
more depence may require a larger dose of an intervention and may also benefit from stepped up 
care, yet most studies focus on a single intervention (Edelman et al., 2017). To this end, there are 
studies being conducted to assess the effectiveness of psychological therapies in HIV in addressing 
mental health and drinking problems (Madhombiro et al., 2017; Parry et al., 2014). Limited access to 
skilled staff may impede the successful implementation of interventions for the management of HIV 
and comorbid alcohol use (Perngparn, Assanangkornchai, Pilley, & Aramrattana, 2008)and there have 
been calls to use task sharing as a way to address the staff and skills shortage (Collins, Musisi, 
Frehywot, & Patel, 2015; Lund et al., 2014; Patel et al., 2007). Given that highly skilled personnel have 
traditionally delivered psychological therapies it is essential to find innovative ways of bridging this 
gap. HIV care providers, such as nurses, could be trained in the safe and effective delivery of 
treatments for problematic alcohopl use in PLWH and in so doing improve medication adherence and 
HIV outcomes (Bernstein et al., 2007). 
Feasibility studies are  necessary to assess (i) contextual factors that may need to be 
incorporated into treatment protocols, (ii) barriers and facilitators to the provision of  interventions, 
(iii) service-related factors and (iv) the availability of resources to deliver the interventions as this can 
potentially influence outcomes (Bernal, 2006). This study sought to obtain baseline data on 
problematic alcohol use using the AUDIT in a nurse driven HIV care setting. In addition, we sought to 
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assess the utility of the AUDIT and obtain pilot data on the effectiveness of an intervention for 
problematic alcohol use, as delivered by registered general nurses. 
Ethics 
The Health Research Ethics Committee of the Stellenbosch University (SI14/10/222), the 
Medical Research Council of Zimbabwe (A/1936) and the Harare Hospital Ethics Committee approved 
this study. 
Aim 
To pilot the outcome assessments to be used in the trial proper, assess the feasibility of 
delivery of a brief MI/CBT intervention compared to an WHO mhGAP intervention for problematic 
alcohol use in PLWH in Zimbabwe, and pilot the effectiveness (on alcohol use, functionality and CD4 
count) of these interventions at 3 months in a randomised controlled trial design functional capacity 
Methods 
Recruitment 
Recruitment of participants took place from the 8th to the 28th January 2016. The final 
assessment of outcomes was completed on the 30th of April 2016. The study setting was a tertiary 
HIV clinic run by nurses and medical doctors. Research assistants recruited participants during their 
routine clinic attendance. Informed consent was obtained from willing participants. Baseline data 
were collected on all participants and the interventions were delivered in February and March 2016. 
A computer-generated randomization schedule was used to assign participants to the two 
interventions. As a retention strategy, we noted the contact details of participants and their 
significant others and reminded participants of their appointments on the day prior to their study 
visits. 




Harare Central Hospital HIV care clinic which is a tertiary level clinic. Patients were referred 
from acute medical wards and primary care clinics in the city of Harare and Zimbabwe as a whole. 
Inclusion and exclusion criteria 
Participants were adults aged 18 years and older. In order to be included, female participants 
had to score at least 6 and male participants at least 7 (Perula-de Torres et al., 2005), respectively, on 
the Alcohol Use Disorders Identification Test (AUDIT), scores that are indicative of problematic 
drinking (www.who.int/substance_abuse/publications/audit/en). There is evidence that low alcohol 
consumption in HIV positive individuals is associated with increased harm than in HIV negative 
adults(R. Scott Braithwaite et al., 2008). Participants were screened for cognitive impairment with 
the International HIV Dementia Scale (IHDS) with those by scoring 10 or less excluded. A score of 11 
and below indicated cognitive impairment.  Mental illness was assessed with the Substance Abuse 
Mental Illness Symptom Screener (SAMISS)(Whetten et al., 2005). Positive responses to questions 8-
16 are suggestive of mental illness while questions 1-7 are suggestive of alcohol and other substance 
use problems. The Drug Use Disorders Identification Test (DUDIT) assesses other substance use with 
positive cut-points of 2 or more for females and 6 or more for males (Berman, Bergman, Palmstierna, 
& Schlyter, 2005). Participants had to be in receipt of HIV treatment at the clinic and receiving 
followed-up care for at least three months. 
Nurse training 
Ten registered general nurses were invited to participate. Training included the use of 
PowerPoint presentations, role-play, quizzes and assignments. Training was provided both in a 
classroom setting and on-site. Both interventions were manualised and 5 nurses each were trained 
in these interventions. The trainers included two psychiatrists, a nurse practitioner and a clinical 
psychologist. The training was conducted over two days with the first day covering Good Clinical 
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Practice and ethical principles for both groups of nurses. However, groups were separated on Day 2 
of the training with each group receiving training in either MI/CBT or the WHO mh-GAP IG. 
Quality assurance 
Consent was obtained from the nurses to audio-record the training and this formed the basis 
of supervision whereby the recordings were collectively reviewed and feedback provided in order to 
facilitate the acquisition of a similar level of skill among the nurses. Ten percent of the sessions that 
were administered and audiotaped were reviewed with the nurses and feedback was provided during 
supervision visits. The 7 sessions that were audio taped were reviewed at the 4 supervision sessions 
that were held during the study. The supervision visits were held on days and times when the clinic 
was closed to patients for medication collection. Where inconsistencies were noted, further training 
was provided, both in individual and group supervision format. Client evaluation and satisfaction 
cards were reviewed with each nurse, and where concerns were identified, they were discussed and 
resolved. 
MI/CBT Intervention 
The MI/CBT intervention comprised a combination of motivational enhancement and 
cognitive-behavioural techniques and was an adaptation of these evidence-based therapies for 
problematic alcohol use  (Sobell, Breslin, & Sobell, 1998).("Matching alcoholism treatments to client 
heterogeneity: treatment main effects and matching effects on drinking during treatment. Project 
MATCH Research Group," 1998) Motivational interviewing is a therapy developed by William Miller 
and Stephen Rollnick to treat patients with problematic alcohol use(Miller WR). It can also be used 
for other problematic behaviours. Patients with unhealthy alcohol use can change their drinking 
patterns when sufficiently motivated through counselling that emphasizes empathic listening, 
avoiding arguments, rolling with resistance, and self-efficacy. Cognitive behavioural therapy (CBT) is 
a treatment based on the premise that certain behaviours are the result of faulty thinking. Drinking 
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behaviour is associated with certain thinking patterns that result in cravings that can be addressed by 
CBT. Drinking can also be avoided if the patient has certain drink refusal skills that can be developed 
through CBT. 
The intervention comprised 4 sessions, with each session delivered in two parts as shown in 
Table 1. The duration of these sessions ranged from 30 minutes to one hour. Table 1 shows the 
content (Miller WR)and duration of sessions. The motivational enhancement therapy themes 
included providing personal feedback on alcohol use, ‘change talk’ themes, and readiness to change 
the ‘ruler’. The cognitive therapy elements encompassed setting goals, dealing with cravings and 
cues, faulty thinking patterns, dealing with stresses, and developing ‘drink refusal’ skills. Problem 
solving skills were also included in the intervention. All of the intervention sessions were audiotaped 
and reviewed with the intervention staff to facilitate uniformity in the delivery of the intervention. 
Session 1a, 30 
minutes 
General life personal goal setting 
Alcohol goals  
General life personal goal setting 
How alcohol use interfere with goals 
Session 1b, 30 
minutes 
Possible reasons why people drink  
Establish you clients’ reasons for drink: 
Providing personal feedback moving the client towards change 
Explaining the implications of drinking on treatment as indicated on CD4 and 
viral load 
Meaning of improvement and the value of a functional life and quality of life. 
Drinking problems warning signs 
Session 2a, 30 mins Use MI to build rapport and develop readiness to change  
Assess readiness to change (using readiness ruler) 
Assess pros and cons of change (Decision-balance exercise) 
Use MI to try and shift participant  
Elicit a commitment to change 
Session 2b, 30 
minutes 
Brief explanation and principles of CBT 
Explanation on what triggers, urges and cues are and how they lead to 
drinking 
Discussion on how triggers arise and how they lead to use and effects. 
Managing thoughts about drink 





Drink refusals skills 
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Managing situations were drinking are unavoidable 
Session 3a, 30 
minutes 
Dealing with specific treatment issues like: 
Receiving viral load and CD4 results, treatment problems, Losing a spouse, 
Employment threatened by illness, New illness related to the viral infection 
Running out of medication 
Session 4, 30 
minutes  
Planning future direction 
Life is back to normal: Do I drink? 
Dealing with anger and criticism 
Dealing with failure 
Self-referral 
Conclusion and planning the future 
Table 1: Summary of session content and objectives 
 
WHO mh-GAP IG The World Health Organisation Mental Health Action Programme 
Intervention Guide (WHO mh-GAP IG) was the comparator(Organisation, 2010). The WHO mhGAP IG 
is designed for screening and management of common mental disorders, including problematic 
alcohol use, in primary care settings. It has been used as a control in other studies in low and middle-
income countries (Nadkarni, Weobong, et al., 2017). The WHO mhGAP comprised an assessment of 
alcohol use on history, brief advice on harmful alcohol use, and referral for probable alcohol 
dependence. This intervention was administered in a single session of one hour by trained RGNs. 
Assessment measures 
At baseline `and follow-up, the AUDIT, CD4 count, WHODAS 2.0 and the WHOQoL were 
administered. Follow-up assessments were conducted for both group at three months. 
WHO AUDIT 
The WHO AUDIT was used to screen participants and was also the primary outcome measure. 
The AUDIT is a 10-item tool with a score range of 0 to 40(Bohn, Babor, & Kranzler, 1995; Saunders, 
Aasland, Babor, de la Fuente, & Grant, 1993). In this study, scores of 6 and 7 for females and males, 
respectively, were applied as cut-offs to identify patients with problematic drinking based on 
psychometric performance of the AUDIT in previous studies (Perula-de Torres et al., 2005). Some 
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studies have shown that HIV infected individuals require much less alcohol to get intoxicated and 
suffer physiologic harm(Justice et al., 2016; McGinnis et al., 2016). Although the AUDIT has not been 
validated in Zimbabwe or among people living with HIV, it has been used in diverse population groups 
in Southern Africa and in Zimbabwe(Chandiwana et al., 1999; Chinyadza et al., 1993). The AUDIT has 
good psychometric properties with a Cronbach alpha of 0.93 [95% CI (0.921-0.941)], specificity of 
89.6% (95% CI, 76.11-96.02 and sensitivity of 95.07% (95% CI, 92.18-96.97) against gold standard 
DSM-IV criteria, at a cut point of 6 (Perula-de Torres et al., 2005). The Cronbach alpha for the AUDIT 
in this study was 0.72. 
Viral load and CD4 
Trained general nurses collected blood for baseline viral loads and CD4 count. These assays 
were done at the hospital laboratory. As a result of budgetary constraints, viral loads were not done 
at the 3-month assessment. 
World Health Organisation Disability Assessment Schedule 2.0 (WHODAS 2.0) 
The WHODAS 2.0 is a tool developed by the WHO to assess the degree of disability and has 
been validated for a variety of health conditions(Garin et al., 2010; www.who.int/icidh/whodas/; 
www.who.int/mental_health/media/en/613.pdf). Although the WHODAS 2.0 has not been validated 
in Zimbabwe, it has been used in rural Ethiopia and was found to have good psychometric properties 
with an internal consistency ranging from very good to excellent (Crobach’s alpha 0.82 to 
0.98)(Habtamu et al., 2017). The WHODAS 2.0 has been validated for chronic diseases, such as HIV, 
and had good psychometric features(Garin et al., 2010). The Cronbach alpha for the WHODAS 2.0 in 
this study was 0.91. 
World Health Organisation Quality of Life HIV (WHOQoL HIV) 
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Quality of life was assessed using the WHO Quality of Life HIV (WHOQoL HIV) that has been 
validated for HIV elsewhere but not in Zimbabwe(Group, 2004; Hsiung et al., 2011; 
www.who.int/mental_health/media/en/613.pdf). The WHOQoL HIV has been validated in South 
Africa and Zambia and has good internal consistency with Cronbach alphas ranging from 0.889 to 
0.933 in the Zambian study(Mweemba, Zeller, Ludwick, Gosnell, & Michelo, 2011; Van Biljon, Nel, & 
Roos, 2015). The Cronbach alpha for the WHOQoL HIV in this study was for 0.9 D for domain I, 0.59 
for domain II, 0.92for domain III,.and 0.49 for domain IV. 
Data analysis 
Data were analysed using Stata version 14(StataCorp. 2015. Stata Statistical Software: Release 
14. College Station). Intention to treat was the approach to analysis. The standardized mean 
difference of the AUDIT score was the measure of treatment effect. We summarized continuous 
variables using means (standard deviation) or medians (interquartile range) depending on the 
distribution, and categorical variables using counts (percentages). We used t-tests or Mann-Whitney 
U tests to compare means or medians between the two intervention groups. We used chi-square 
tests or Fisher's exact tests to test the association between study groups and other categorical 
variables. Alpha was set at = 0.05 and all tests were two sided. 
Results 
Recruitment, randomisation and retention 
One hundred and two (102) patients were invited to participate in the study. At screening, 33 
scored less than 6 on the AUDIT and 69 had scores at or above the cut-off. Eleven participants failed 
to meet the eligibility criteria and 18 declined to participate for reasons including moving away from 
Harare, work commitments and other reasons. Forty participants were randomised to each group 
with no baseline differences between the groups, as shown in Table 3. At follow up, 4 participants 
were lost in the MI/CBT group and 5 in the mhGAP IG group. Three participants in the MI/CBT group 
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and 4 in the mhGAP IG group relocated from Harare, while 1 participant in the MI/CBT group and 1 
in the WHO mhGAP IG group were unable to secure time off from work (see Fig. 1). 
 
Figure 1 shows the study flow from screening to analysis.   
 
 
KEY: means Control*pre; means Control*post; means Intervention*pre; means Intervention*post 
Table 3 is showing AUDIT SCORES between MI/CBT and mhGAP  




















control*pre control*post 8.05 1.95 0.00
control*pre intervention*pre 1.20 2.07 0.57
control*pre intervention*post 8.85 2.07 0.00
control*post intervention*pre -6.85 2.07 0.00
control*post intervention*post 0.80 2.07 0.70
intervention*pre intervention*post 7.65 1.95 0.00
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Baseline characteristics  
There were 17 female and 23 male participants in the study. The combined mean age was 
39.5 years (SD=9.59), with a mean age of 41.7 years (SD=9.61) in eth MI/CBT group and a mean age 
of 37.3 years (SD=9.29) in the mhGAP IG group. Table 2 shows the socio-demographic characteristics 
of the sample. At study entry, 6(15%) participants were on second line HAART and 34(85%) had 
achieved viral suppression. Participants had been on HAART for 3.5(SD1.2) years. The MI/CBT group 
had a significantly lower median CD4 count 201.5 (range of 85 to 367) than the mhGAP group 
390(range of 200 to 400) (p=0.03). Table 2 Shows the sociodemographic features of the study 
population. The participants were predominantly male and more than 50% were married. 
 Frequency Mean Standard deviation 
Age  39.5 9.59 
Females (%) 17 (42.50)   
Males (%) 23 (57.50)   
Marital status    
Single (%) 7 (17.50)   
Married (%) 21 (52.50)   
Divorced (%) 6 (15)   
Widowed (%) 6 (15)   
Education -years in school   3.10 
Interventions 
A total of 74 interventions sessions were administered with a median of 3.7(1 to 4 sessions) 
sessions per participant and 14.8 sessions per nurse. The duration of sessions ranged from 30-55 
minutes.  In the mhGAP group, each nurse conducted a single session of the mhGAP at the first 
contact. A total of 20 sessions were administered to this group. 
Outcomes 
Alcohol use outcomes 
There was no statistically significant difference in the AUDIT score at baseline (p=0.57) 
between the groups as shown in Table 2. There was a statistically significant change in alcohol use in 
both groups over time (p <0.0) as shown on Table 2. There was no difference in the magnitude of 
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change between the groups as shown the 95% confidence intervals in Fig 2. In the MI/CBT group, 
there was a change in mean AUDIT score from 14.85(7.78) to 7.20(5.07) and for the mhGAP IG group, 
the mean AUDIT score changed from 16.05(7.20) to 8.00(5.79) over time as shown in Table 4. 
 
Figure 2 is showing the AUDIT for both arms. Both arms recorded significant falls in their AUDIT Score. 
 
 
Table 4 Descriptive Statistics is showing comparisons between Audit scores between both arms   
CD4 
Due to the skewness in the data, we report medians and interquartile ranges.  At follow-up, 
the median and interquartile ranges for the MI/CBT and mhGAP IG groups were 390(280) and 
group*time; LS Means
Current effect: F(1, 38)=.02107, p=.88535
Type III decomposition














































control 40 12.02 7.63
intervention 40 11.03 7.55
pre 40 15.45 7.43
post 40 7.60 5.39
control pre 20 16.05 7.21
control post 20 8.00 5.79
intervention pre 20 14.85 7.78
intervention post 20 7.20 5.07
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567(378), respectively, indicative of improvement in immunological parameters although groups 
differences were not statistically significant as shown in Table 5 and Fig 3  
 
Source MI/CBT Median MI/CBT IQR MH GAP IG Median MH GAP IQR 






















Figure 3 is showing the CD4 Count for both arms. Group control represents the mh GAP IG arm and 
group intervention represents the MI/CBT arm. 
 
Functioning and quality of life  
Functioning and quality of life, as measured on the WHODAS 2.0 and the WHOQoL HIV, 
showed no change over time. 
group*time; LS Means
Current effect: F(1, 29)=.33917, p=.56481
Type III decomposition
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WHODAS MEAN STAND ERROR STD DEV 95% C I 
Baseline     
MI/CBT  13.7     1.54     6.88    10.48    16.92 
mhGAP 15.5     1.45 6.48     12.47    18.53 
                 
3 months     
MI/CBT 13.44    .95 3.80    11.42    15.46 
mhGAP 13.27     1.12     4.35     10.86    15.68 
               
Table 6 is showing the disability for baseline and 3 months  
WHOQOL MEAN STAND ERROR STD DEV 95% C I 
Baseline     
MI/CBT 23.65     .69     3.07      22.22    25.05 
mhGAP  22.63     .86     3.73    20.83    24.43 
             
3 months     
MI/CBT  22.33      .80     3.11     20.61    23.84 
mhGAP 22.94     .42     1.70     22.06    24.06 
                
Table 7 is showing the quality of life for baseline and 3 months 
Discussion 
The aim of this study was to pilot the outcome assessments to be used in an adequately 
powered trial, assess the feasibility of delivery of a brief MI/CBT intervention compared to an WHO 
mhGAP intervention for problematic alcohol use in PLWH in Zimbabwe, and assess their preliminary 
effectiveness using a task-sharing model in a low resource setting with a huge HIV burden. This 
sample of 40 HIV infected patients was drawn from an HIV care setting at a tertiary institution where 
participants received either blended motivational interviewing/CBT or the WHO MH GAP IG. The 
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retention rate was 77% at 3 months with no statistically significant group difference.  In both groups, 
drinking behaviour as assessed by AUDIT score and CD4 count improved after treatment. 
Improvement in alcohol use in this population supports previous findings that participation in 
screening and exposure to alcohol counselling, and receipt of pamphlets or presentations can lead to 
reduction in alcohol use(Brown et al., 2013). Studies have shown that in participants with early and 
low levels of alcohol use, low intensity interventions can lead to change in the level of alcohol 
use(Babor, Ritson, & Hodgson, 1986). However, studies have also shown that patients who are 
dependent on alcohol do not change their drinking behaviour even with longer exposure to 
interventions (Moyer, Finney, Swearingen, & Vergun, 2002). Although we hypothesized that MI/CBT 
would result in a greater reduction in drinking than the mhGAP IG, this was not the case. Both 
interventions could be considered as ‘active’ treatments. There has been a call to adapt and test 
treatments such as the WHO MH GAP IG, that are scalable in low- and middle- income 
countries(Baingana, al'Absi, Becker, & Pringle, 2015). 
Although there was change in the CD4 count in both groups, this was not statistically 
significant. Some studies have found no relationship between alcohol use and CD4 count(Azar, 
Springer, Meyer, & Altice, 2010). Functional capacity and quality of life did not show any change over 
time in the trial. The small sample size may have contributed to the lack of detection of a significant 
effect 
The loss to follow up was 23% despite retention efforts such as confirming appointments. 
Follow up assessments did not always coincide with scheduled clinic visits. Participants at the clinic 
at which recruitment took place (a tertiary institution) are poorly adherent, have late stage disease 
and high rates of treatment failure. These are some of the characteristics of loss to follow up that 
were documented in a study in Ethiopia(Megerso et al., 2016). 
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The study provides preliminary evidence that registered general nurses can be trained to offer 
a psychological intervention for dually diagnosed adults with HIV and unhealthy alcohol use. In 
Zimbabwe, nurses are at the forefront of provision of both curative and preventive interventions in 
Zimbabwe. While task sharing an intervention for unhealthy alcoholuse to nurses may be novel, 
nurses have been at the forefront of provision of HIV treatment with results that are comparable to 
those achieved by doctors(Fairall et al., 2012). 
This pilot study has a number of limitations. It is characterized by a small sample and, as such, 
not adequately powered to demonstrate true treatment differences and hence prone to Type I error. 
Further, the alcohol screening used the AUDIT, which is a self-report tool. As a result, has social 
desirability bias(Davis, Thake, & Vilhena, 2010). The study was undertaken at a tertiary institution 
which serves as a referral centre for patients and not in primary or district care settings, thus 
morbidity present in the sample may not be reflective of HIV patients receiving care in the latter 
settings. 
Conclusion 
This study demonstrates the feasibility of administering the assessment tools employed here 
and delivering a brief MI/CBT intervention in HIV care clinics. The interventions led to change in 
alcohol use. Further large samples studies that are adequately powered are needed. Strategies to 
retain participants need to be carefully considered when integrating interventions for alcohol use 
treatment into usual care. 
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Title: A cluster randomised controlled trial protocol of an 
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Abstract 
                       Background Alcohol use disrupts effectiveness of HIV management throughout the HIV 
care cascade. There is paucity of data on effectiveness of interventions for problematic alcohol use 
in the context of HIV infection, diagnosis and treatment especially in Low- and Medium-Income 
Countries (LMIC). Due to shortage of health care workers especially psychosocial specialists to deliver 
the interventions for alcohol disorders, task-sharing models of care are essential.  We conducted a 
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cluster randomised controlled trial to assess the effectives of an intervention for problematic alcohol 
use and on alcohol use reduction, viral load reduction, CD4 improvement, functionality improvement 
and change in quality of life among people living with HIV/AIDS(PLWH) in HIV care clinics in 
Zimbabwe. 
                Methods We conducted a cluster randomised controlled trial involving 16 HIV care clinics 
that were randomly selected from a total of 109 clinics in Zimbabwe. Clinics were randomly assigned 
(1;1) to a motivational interviewing/Cognitive behavioural therapy (MI/CBT) intervention or a World 
Health Organisation Mental Health Gap Action Program Intervention Guide (mh GAP IG) control. The 
treatments were both manualized and delivered by trained registered general nurses (RGNs). The 
primary outcome was a reduction in alcohol use as measured by the alcohol use disorders 
identification test (AUDIT) score (Mean Difference). The secondary outcomes were change in viral 
loads, CD4 count, functionality and quality of life. Participants were not blinded to treatment, 
however, research assistants who assessed outcomes were blinded. The trial was registered with Pan 
African Clinical Trial Registry, PACTR201509001211149. Registered 22 July 2015. 
                   Findings 234 PLWH with problematic alcohol use were recruited from 16 HIV care clinics 
in Zimbabwe between December 2016 to September 2017. 
Eight clinics each were assigned to MI/CBT and mh GAP IG, with 25 RGNs in each arm. The MI/CBT 
arm recorded a statistically significant reduction in AUDIT score 3.33(1.88;4.78) p <0.001 at 3 months 
and a further reduction 2.41(0.99;3.83) p <0.001 at 6 months.   The mh GAP IG recorded a statistically 
significant reduction in alcohol use only up to 3 months 2.53(1.25;3.81) p < 0.001. There were 
statistically significant differences (p=0.05) between MI/CBT and mh GAP IG in favour of the MI/CBT. 
There was a statistically significant change in the viral load from baseline to 6 months for MI/CBT 
0.77(0.41;1.13) p-value <0.001 and mh GAP IG 0.40(-0.51;0.84) p=0.0408. There were no statistically 
significant group differences on viral loads between the MI/CBT and mh GAP IG (p=0.46). The 
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functional capacity improved between 3 and 6 months ((MD0.95 95% CI (0.10; 1.80) p =0.029) and 
mh GAP IG (MD 1.25 95%CI (0.39;2.52) p= 0.008). There was significant improvement in quality of life 
in both groups between 3 to 6 months ((MI/CBT MD-13.63 95%CI (-17.05; -10.21, p <0.001; mh GAP 
IG MD -12.21 95% CI (-14.71; -9.72) p<0.001).  
           Interpretation Interventions for problematic alcohol use delivered by RGNs in PLWH lead to 
reduction alcohol use. An adapted MI/CBT resulted in sustained improvement compared to an mh 
GAP IG. Further, viral load, functional capacity and quality of life improved in PLWH who are exposed 
to an intervention of problematic alcohol use. Substantial improvements in HIV treatment outcomes 
can be achieved by incorporating interventions for problematic alcohol use in PLWH in low resource 
and high HIV burden settings like Zimbabwe. The findings from this study may be incorporated in 




HIV remains a global priority for the following reasons;  0.8% of adults 15-49 years of age living 
with HIV worldwide, it has caused 37 million death, close to 2 million  new infections occur in a single 
year and 1 in 25 adults infected with HIV in Sub-Saharan Africa(1). In response, Joint United Nations 
Program on HIV/AIDS (UNAIDS) has come up with the 90-90-90 targets. The targets are that 90% of 
HIV infected people should know their status; 90% should be accessing antiretrovirals; 90% should 
achieve viral suppression by 2020(2). The goal is to have an HIV/AIDS-free world by 2030(3). In order 
to achieve these targets, the HIV testing must be intensified; more people have to be put on 
treatment through increased resource mobilization and allocation; adherence has to be optimal so 
as to achieve adequate viral suppression. Alcohol use has been implicated in increased vulnerability 
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to HIV infection, delay in HIV testing, inadequate adherence to ART leading to failure to achieve viral 
suppression(4-6). 
Studies have documented a high prevalence of problematic alcohol use in PLWH, with studies 
from the USA showing that they may be twice as common in PLWH as in non-infected individuals(7). 
Systematic reviews indicate that alcohol contributes to increased rates of infection as it is associated 
with risky sexual practice(8, 9).   PLWH are less likely to get tested early for HIV, are more likely to be 
lost to care early, are unlikely to achieve the required levels of adherence to treatment, have 
heightened disease progression and in general have poor outcomes to treatment (10, 11). In PLWH, 
alcohol is also a potent immunosuppressant and has effects on the liver that may affect the 
metabolism of ARVs and potentially result in ARV toxicity(12).  Further, it has also been shown that 
PLWH need less alcohol consumption to feel drunk and suffer more physiologic harms with lower 
alcohol consumption(13). It is therefore necessary to come up with different drinking guidelines for 
PLWH considering the effects of alcohol on their health achieve good treatment outcomes.  
Alcohol has also been associated with the acquisition of HIV infection through non-use of 
preventive measures such as condoms, pre- and post- exposure prophylaxis (PrEP and PEP, 
respectively) and engagement in risky sexual behaviours(14). Research has also shown that alcohol 
increases infectiousness in HIV positive, as there is an increase in viral reservoirs due to the damage 
of the natural protective vaginal mucosa(15). Alcohol causes cognitive impairment especially memory 
loss leading to inconsistent adherence to treatment, and taking medication out-of-time thereby 
contributing to poor adherence(16). A systematic review on the relationship between alcohol and 
HIV in Sub-Saharan Africa (SSA) showed that alcohol use was associated with HIV transmission(8, 17). 
The effects of alcohol in increasing risky sexual behaviour have also been documented in another 
systematic review in SSA(18).  Empirical data from SSA also found that the risk of unprotected sex 
increased with the quantity of alcohol consumed rather than with the frequency of drinking(19-21). 
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It thus suggests that the effects of problematic alcohol use on HIV are multipronged and may need 
diverse approaches targeting new infections preventive approaches, medication adherence 
promotion and viral loads assessments that are linked to alcohol consumption strategies. 
Although, some studies have shown that psychological interventions are able to reduce 
drinking in settings outside HIV infection, the same outcomes have not been demonstrated in 
addressing alcohol use in  PLWH(22) (23). A systematic review of HIV risk-alcohol reduction and 
adherence improvement through alcohol use control and drinking reduction did not show any 
marked effect(24). Another systematic review assessing the effectiveness of psychological 
interventions on adherence was negative(25). 
Few interventional studies that have been undertaken in SSA, show some benefits in reducing 
alcohol use along HIV treatment cascade however(26-28). Zule et al (2014) in a study conducted in 
South Africa (Cape Town) showed that group intervention was effective in imparting skills to reduce 
risky sex in the context of alcohol consumption, sexual negotiation and condom use mastery and 
exploration of relationships and communication reduced alcohol consumption in females(27). In a 
study with a small sample size, in Kenya, Papas et al (2011) showed that CBT can reduce alcohol 
consumption in PLWH (26). Wandera et al (2017) in Uganda found that a brief intervention reduced 
alcohol consumption in females, although there were no effects in males(28). Qualitative studies 
suggest that PLWH are aware of the effects of alcohol on ART have and are willing to engage in 
behavioural interventions for AUDs (29, 30). A study from Uganda showed an increase in abstinence 
from alcohol, in individuals who had commenced ART suggesting that once tested for HIV and on 
treatment there is an effort to abstain(31). 
 According to the World Health Organisation (WHO) there are an estimated 22.5 mental 
healthcare workers for every 100000 population reflecting a 79% gap(32). Yet the need for the 
populations and the populations are increasing. In order to meet this need and close the treatment 
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gap, there is therefore need to adapt interventions for problematic alcohol use and adopt task sharing 
in health care in general and in alcohol use reduction treatment in particular. The treatments can be 
delivered by less trained cadres, as recommended by the World Health Organisation WHO(33). 
Studies in HIV care delivery have shown that the quality and outcomes of treatment delivered within 
a task-sharing model are similar to that delivered by physicians(34). In Zimbabwe, Chibanda et al 
(2016) showed that lay health workers can effectively deliver a cognitive behavioural therapy for 
depression(35). 
Interventions for problematic alcohol use must target alcohol use, non-adherence to 
treatment and risky sexual behaviour that have all been shown to negatively affect adherence. 
Objectives 
1. To evaluate the effect of an adapted Motivational Interviewing and Cognitive Behavioural 
Therapy (MI/CBT) intervention in people living with AIDS (PLWH) on alcohol use outcomes 
using the Alcohol Use Disorders Identification Test (AUDIT) score. 
2. To assess whether an adapted MI/CBT intervention for problematic alcohol use in PLWH 
compared with the World Health Organisation mental health GAP Intervention Guide (mh 
GAP IG) as delivered by Registered General Nurses (RGN) improves their functional ability 
and quality of life. 
3. To establish whether an adapted MI-CBT intervention for alcohol use in PLWH compared 
with mhGAP IG as delivered by RGN can lead to better treatment adherence in Zimbabwe as 
measured by viral loads and CD4. 
Methods 
The study was a 2-arm cluster randomised controlled trial. The clinics were stratified by level 
of care, into provincial (tertiary care), district (secondary care), church related (secondary care but 
funded by churches) and city health polyclinics (primary care). The intervention arm was an adapted 
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motivational interviewing and cognitive behavioural therapy based on Project MATCH manuals (36). 
The developed intervention was piloted at an HIV care clinic in Harare. The pilot helped assess the 
duration of the intervention and was adjusted accordingly. The comparator was a section of the 
World Health Organisation Mental Health Gap Action Program   Intervention Guide(mh GAP IG) that 
deals with the management of alcohol use,  developed for primary care settings but used in research  
in other countries(37). 
Clinic recruitment 
The HIV care clinics in the study were randomly selected as follows; provincial clinics (n=2), 
district hospitals (n=7), church related clinics (n=4) and city health clinics (n=3). A study investigator 
used a computer-generated algorithm that assigned clinics on a 1;1 to the MI/CBT and mh GAP arms 
(8 clinics per arm). We randomly selected 450 patients per HIV care clinic. We obtained their contact 
numbers and locations and reached out to them requesting their participation in the study. 
Allocation concealment 
The trial statistician generated the randomisation schedule and provided this to the research 
team for the recruitment of participants. 
Participant recruitment 
Participants were HIV positive individuals recruited from HIV electronic database kept at the 
HIV care clinic. This is a database that is hospital based and linked to the Zimbabwean national 
HIV/AIDS program. The database was screened to exclude those who did not meet our initial eligibility 
criteria, namely patients less than 18 years of age, or not followed up at the clinic in the previous 3 
months. From the remaining patients in the database, 450 were randomly selected and contacted, 
with the aim of recruiting 15 participants. Research assistants, used the contact information in the 
database to locate potential participants. The research assistants then explained the study to the 
Stellenbosch University  https://scholar.sun.ac.za
125 
 
potential participants. To the participants who gave initial consent, the AUDIT was administered on 
them. Females were required to score 6 or more on the AUDIT or greater and males needed a score 
of 7 or greater to be included. The decision to use the cut-off of lower for females was based on the 
recognition that females get more harm with lower alcohol consumption(38). The score with good 
specificity and sensitivity is 8, however, in this study we used a lower cut-off of 6/7 as the AUDIT has 
not been validated and there are high levels of unrecorded alcohol consumption in the areas that 
were under study(39). 
Other exclusion criteria included patients who were on treatment for alcohol and any other 
substance use, had florid mental illness. Two hundred and ninety-six patients were excluded as they 
did not meet the inclusion criteria, while 109 declined to participate. Figure 1 (CONSORT diagram) 
shows the flow of the study.  
The International HIV Dementia Scale (IHDS) was used to screen for the presence of dementia 
with a cut off of 10 applied (40). The Drug Use Disorders Identification Test (DUDIT) and the Substance 
Abuse Mental Illness Symptom Screener were used to screen for presence of other substance 
abuse(41). Participants with severe other substance use as assessed by the DUDIT were excluded. 
The M.I.N.I (Mini International Neuropsychiatric Interview) was the gold standard psychiatric 
diagnostic interviews(42). 








The intervention was a blended motivational interviewing and cognitive behavioural therapy 
(MI/CBT). The intervention was made into a manual and consisted of 8 sessions delivered by RGNs. 
The intervention was based on themes covered in  Project MATCH Motivational Enhancement 
Therapy(MET) and Cognitive Behavioural Therapy (CBT) manuals(43). Other aspects covered included 
feedback to participants on the risks associated with drinking whilst on HIV treatment. Emphasis was 
on the link between HIV and alcohol use, feedback on AUDIT scores, the viral load and CD4.  
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The participants had to be booked and allocated to a specific nurse who had to complete the 
full treatment. The booking system was adopted to avoid disrupt normal clinic’s activities.  The 
sessions were audio-recorded with consent to do so having been received. The recording was done 
for use in feedback for RGNs, for checking and improving fidelity.  The MI/CBT training team was 
made up of (MM, BD and TM). The mh GAP IG was made up of (MD and WM). The two teams   
provided two supervision sessions to each clinic at 3 months. The supervision consisted of review of 
sessions conducted, review of audio-records of 10% of the records and participants record cards.  
Table 1 provides the MI/CBT content. 
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Table 1 describes the content of the MI/CBT intervention. 
 
Session 1, 45 minutes   Goal setting 
    General life personal goal setting 
    Alcohol goals 
    How alcohol interferes with goals 
 
Session 2, I hour   HIV and drinking 
    Possible reasons why people drink 
    Establish client’s reasons for drinking 
    Provide personal feedback 
    Moving the client towards change 
Examine the impact of drinking on HIV treatment, CD4 count and viral load 
Meaning of improvement and the value of functional life and quality of life 
Drinking problems and warning signs 
 
Session 3, 1-hour   Motivational interviewing and the intervention 
    Use MI to build rapport and develop readiness to change 
    Assess readiness to change (using readiness ruler) 
    Assess pros and cons of change (decision-balance exercise) 
    Use MI to try and shift participant 
    Elicit a commitment to change 
 
Session 4, 30 minutes  Cognitive behavioural therapy and intervention 
    Brief explanation and principles of CBT 
Explanation on the triggers, urges and cues are and how they lead to drinking 
Discussion of how triggers arise and how they lead to alcohol use and its effects 
    Managing thoughts about drinking 
 
Session 5, 45 minutes  Triggers and relapse 
    External  
    Internal 
    Drinking refusal skills 
    Managing situations where drinking is unavoidable 
 
Session 6, 30 minutes  Dealing with specific treatment issues like:  
    Viral load and CD4 count results, treatment problems 
    Loosing spouse 
    Employment compromised by illness 
    Illness complications related to HIV infection 
    Running out of medication 
 
Session 7, 1 Hour   Planning future direction 
    Life is back to normal: Do I drink? 
    Dealing with anger and criticism 
    Dealing with failure 
    Self-referral 
Session 8, 1-hour   Conclusion and planning the future 
 
 
Mh GAP IG 
RGNs administered the mh GAP IG alcohol use section using manuals.  Besides counselling on 
alcohol use, participants received feedback on their AUDIT score, CD4 count and viral load. 




Two teams trained the RGNs, one team exclusively undertaking training in the MI/CBT 
intervention and the other team training on the mh GAP IG. The training involved PowerPoint 
presentations, quizzes and role-plays. The training took place at the clinics requiring no more 
resources such as transport and allowing the RGNs to provide their usual care. The training for MI/CBT 
lasted 6 hours, while mh GAP IG training lasted 3 hours. Refreshments and a per diem allowance were 
provided to the trained RGNs.  
Table 2: Details of training of intervention staff in MI/CBT and mh GAP IG. 
Intervention delivery  
Of the 104 RGNs in that were trained, 25 actives in each arm during the trial (54 were not able 
to participate as they were assigned to other clinic duties). One thousand and thirty-two sessions 
were delivered in the MI/CBT intervention and 528 in the mh GAP IG control (129 sessions per clinic 
in the MI/CBT and 66 sessions per clinic in the mh GAP IG arm). The participants in the MI/CBT were 
seen once every 2 weeks for twelve weeks and once a month for 12 weeks those in the mh GAP IG 
were seen once every month for at baseline, followed by 1 session, at three months and at 6 months 
where the outcome measures were taken. Participants in MI/CBT intervention and mh GAP IG 
received a mean (SD) of 9.56(3.52) and 4.19(2.33) sessions, respectively.  
VARIABLES MI/CBT mh GAP IG  Total 
Number of Sites 8 8 16 
Number of Participants 108 126 234 
Number of Active Nurses 25 25 50 
Number of Sessions 1 032 528 1 560 
Mean number of sessions per site 129 66 97.5 
Mean number of sessions per participant 9.56 4.19 6.67 
Mean number of participants per nurse 4.32 5.04 4.68 




Both the MI/CBT and mh GAP IG were manualised.  This was done to improve fidelity. Further, 
the trainings were conducted by the same team on each arm. Further all the sessions were audio-
taped, with 10% of the in MI/CBT and mh GAP IG were audio-tapes reviewed. Participants record of 
intervention experience were also reviewed. The deviations from the protocol were corrected 
through additional training of the sites that showed deviations from the protocol.   The nurses also 
kept a record of the sessions, with information such as the duration of the session, difficulties 
experience in the session. 10% of these records were reviewed and used to improve on the 
intervention delivery. Uniformity in training, assessment of the participants records, nurse records 
and audio-tapes ensured maximum fidelity to the protocol.  
Outcomes 
Primary outcomes 
The primary outcome was the Alcohol Use Disorders Identification Test (AUDIT) score at 3 and 
6-months follow-up.  The AUDIT was developed to screen for alcohol use in primary care settings and 
has not been validated in Zimbabwe. It has been validated in HIV populations in South Africa(44, 45). 
Secondary outcomes 
The secondary outcome measures were the functionality measured by World Health 
Organisation Disability Assessment Schedule 2.0(WHODAS 2.0)(46), quality of life measured by the 
World Health Organisation Quality of Life HIV (WHOQoL HIV)(47), viral load and CD4 count. 
The WHODAS 2.0 is a 12-item tool that measures functional capacity in 6 domains that include 
mobility, life activity, cognition, participation, self-care and getting along(48). The WHODAS 2.0 has 
been validated in other HIV populations but has not been validated in Zimbabwe HIV population. The 
WHOQoL HIV assesses the quality of life in the context of HIV(47).  The WHOQoL HIV has 6 domains, 
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which include physical health, psychological health, level of independence, social relationships, 
environmental health and spiritual health(49). The WHOQoL HIV has however been validated in 
Ethiopia and Zambia (50, 51). The WHOQoL has not been validated in Zimbabwe. 
Moderator assessments 
The moderator tools were The Multidimensional Scale of Perceived Social Support (MSPSS), 
Davidson Trauma Scale (DTS) and The COPE 13. The MSPSS assesses for perceived social support from 
Family, friends and Significant Others(52, 53). The scale has 12 items each with 4 items each subscale. 
The DTS is a 17-item self-report questionnaire that assess the impact of trauma that is based on the 
DSM IV(54). DTS assessed for traumatic experience.  The COPE 13 is a tool developed to assess how 
people cope with various situations(55). It has been included in this study to assess how PLWH cope 
with their lives in the light of HIV infection. 
Eligibility tools 
Sample size 
The calculated sample size required to show statistically significant differences between the 
intervention and control of 13% with intra-cluster correlation of 0.02 was 180, with 90 for each arm. 
The pilot estimated loss to follow-up at 30% making the estimated sample size of 240. The RCT was 
able to enroll 234 participants with 108 for MI/CBT arm and the mh GAP IG enrolling 126. 
Blinding 
Participants were not blinded to treatment allocation. In addition, the Principal Investigator 
(MM) was a trainer on the interventions was not blinded. Research assistants who administered the 
outcome measures were blinded to the assignment of clinics. Blinding of research assistants was 
achieved by retaining the same outcome assessors at a site from the baseline, the 3- and 6-months 
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assessments. In order to minimise assessment bias, assessors did not have access to the data 
collected at previous assessments. 
Outcome assessment visits 
At the baseline visit, the AUDIT, SAMISS, WHOQoL HIV and WHODAS 2 were administered. 
The AUDIT, WHOQoL HIV, and WHODAS were administered at 3 and 6 months. The CD4 count and 
viral load were measured at baseline and at 6 months.  
Statistical methods 
Management of missing data 
 All participants were analysed in the arm that they were allocated to at recruitment. 
Clinic level  
All clinics randomized at cluster level were analysed by the treatment arm allocated at 
randomization. 
Participant level 
All participants were included in the analysis of primary and secondary outcomes. 
Analysis approach 
Data were analysed using SPSS. A mixed model ANOVA was used in data analysis. Primary and 
some secondary outcomes were measured at three time points: baseline, 3 and 6 months. To account 
for the stratified cluster trial design, the repeated binary and linear nature of primary and secondary 
outcomes a Generalised Estimation Equations (GEE) approach was used. Descriptive statistics were 
computed for baseline and follow-up assessments. Mean AUDIT scores were compared between 
groups using student t-tests. Multilevel logistic regression was performed for binominal and 
multilevel linear regression for continuous variables. 
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Analysis of covariance (ANCOVAs) and mixed effects linear regression models were performed 
for all continuous variables. Generalised linear mixed effects logistic regression model was performed 
for binary outcomes. All analyses allowed for within-clinic clustering. 
Ethical considerations 
This study received approvals from the Stellenbosch Health Research Ethics Committee 
(HREC) (SI/10/14/222) and the Medical Research Council of Zimbabwe (MRCZ) (A/1936). In order to 
promote quality control and quality assurance of the study, research staff and the Principal 
Investigator received training in research ethics and Good Clinical Practice. A data research 
coordinator ensured accurate data collection and the secure transfer and storage of electronic data. 
Weekly feedback meetings were held with study personnel, the data manager, and the project 
coordinator to address problems and study-related queries. 
Confidentiality 
Participants were assured of the confidential nature of the study. Anonymity was maintained 
by de-identifying collected data and participants were identifiable by unique identifier codes. Patient-
level data was stored securely on a computer encrypted and password protected for the study. Files 
will be stored in a locked cabinet at the University of Zimbabwe College of Health Sciences, 
Department of Psychiatry for five years. 
Costs and compensation 
Participants were reimbursed for transport costs and refreshments (US$3) for each visit. RGNs 
were compensated for their time at ($5) per session. 




Two hundred and thirty-four participants were recruited from 529 PLWH who were screened.   
There were 108(46%) and 126(54%) participants in the MI/CBT and mh GAP IG arms, respectively. 
There were more males than females in both MI/CBT 91(84.3% and mh GAP IG 93(73.8%) groups. The 
majority of the participants were married (MI/CBT 71(65.7%) and mh GAP 75 (59.5%). The level of 
education was (MI/CBT 10.2(SD 4.2) and mh GAP IG 10.8(SD 3.8). The majority of participants were 
in informal employment/self-employed (MI/CBT 60(47.62 %) and mh GAP IG 66(61.11 %). There no 
statistically significant differences between the arms in all sociodemographic data assessed at 
baseline.  
At baseline, the mean AUDIT scores (SD) for MI/CBT and mh GAP IG groups were 14.9(6.3) 
and 14.7(6.2), respectively and there were no statistically significant differences(p=0.44). The MI/CBT 
arm had a higher log10 viral load 1.86(1.12) than the mh GAP IG arm 1.48(1.41) at baseline which 
were not statistically significant(p=0.13). The baseline CD4 were similar with MI/CBT at 338.7(234.6) 
and the mh GAP IG at 338.7(234.6) and there no statistically significant variations(p=0.37). There were 
however no between-group baseline differences on WHODAS 2.0 and WHOQOL. Table 3 gives the 
summary of the sociodemographic and baseline characteristics. 
At baseline, a third of participants screened positive for (71(30%)) other substances use other 
than alcohol, 50% (117) screened positive for depression, 54% (126) for anxiety, while a third 32% 
(75) screened positive for PTSD. There were no significant differences on these measures between 




Stellenbosch University  https://scholar.sun.ac.za
135 
 









Table 4: The table shows the prevalence of substances use and mental illness at baseline. There is 
significant comorbities in PLWH with high levels of depression and anxiety. 
 
Most participants had moderate to high level of support from significant others, friends and 
family (47% to 51%). Participants in both MI/CBT and mh GAP had rates of subthreshold PTSD as 
assessed by DTS with impairment of 29.8 95% CI (24.4;35.2) and 33.7 95% CI (29.6;37.8), respectively. 
Variable MI/CBT Intervention n=108 
(46%) 
Mh GAP IG Control n=126 (54%) 
Age 43.6(SD 9.4) 43.0(SD 9.3) 
Gender   
Female (%) 17(15.7%) 33(26.2%) 
Male (%) 91(84.3%) 93(73.8%) 
Marital status   
Married (%) 71(65.7%) 75(59.5%) 
Divorced (%) 11(6.5%) 12(9.5%) 
Single (%) 10(9.3%) 24(19.1%) 
Widow (%) (%) 7(6.5%) 8(6.4%) 
Co-habit (%) 9(8.3%) 7(5.6%) 
Mean number of years in school 10.77(SD 3.2) 10.19(SD 2.9) 
Main work status (%)   
Paid work (%) 38 (30.16 %) 27(25 %) 
Self-employed (%) 60(47.62 %) 66(61.11 %) 
Non-paid work (%) 3(2.38 %) 4(3.7 %) 
Student (%) 3(2.38 %) 5(4.63 %) 
Keeping house (%) 4(3.17 %) 3(2.78 %) 
Retired (%) 2(1.59 %) 1(0.93 %) 
Unemployed (health reasons) (%)  2(1.59%) 0 
Unemployed (other reasons) (%)  14(11.11 %) 2(1.85 %) 
Duration on HAART 5.36(2.01) 5.12(1.98) 
Clinic ART Adherence 87% 89% 
Baseline Clinical features   
AUDIT Score (SD) 14.9(6.3) 14.7(6.2) 
Log10Viral load (SD) 1.86(1.12) 1.48(1.41) 
CD4(SD) 338.7(234.6) 442.6(236.8) 
WHODAS(SD) 14.6(3.0) 16.2(4.64) 
WHOQoL (SD) 86.3(14.7) 84.4(9.5) 
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There were no baseline differences in coping strategies between the MI/CBT and mh GAP IG, although 
fewer participants (9.6% vs.9.7%) used behaviour disengagement, while active coping, religious 
coping and planning were favoured by more in the MI/CBT (12.0%vs. 10.9) Tables 5,6 and 7 give the  
moderator characteristics. 
 Low Moderate support High support 
Significant others 3(1%) 109(47%) 119(51%) 
Family 8(3%) 110(47%) 116(50%) 
Friends 6(3%) 114(49%) 113(48%) 
Table 5: The table shows perceived support as assessed by the MSPSS. Most participants felt 
supported by family and friends. 
 
Table 6: Shows the coping mechanisms as assessed by the Cope 13. 
 
Table 7: This table shows experiences of trauma as assessed with the Davidson Trauma Scale 
 
Domain MI/CBT mh GAP IG 
Positive reinterpretation 11.3 95%CI (10.8-11.8) 10.0 95% CI (9.6-10.4) 
Mental disengagement 10.6 95%CI (10.2-11.0) 10.5 95%CI (10.2-10.9) 
Focus and venting emotions 10.4 95%CI (9.9-10.8) 10.0 95%CI (9.6-10.4) 
Instrumental social support 11.6 95%CI (11.1-12.1) 9.8 95%CI (9.4-10.3) 
Active coping 12.0 95%CI (10.5-11.3) 10.9 95%CI (11.6-12.4) 
Denial 9.5 95%CI (9.0-10.3) 10.4 95% CI (10.0-10.8) 
Religious coping 12.8 95%CI (12.3-13.2) 11.5 95% CI (11.0-11.8) 
Humor 10.1 95%CI9.5-10.7) 10.1 95% CI (9.5-10.7) 
Behaviour disengagement 9.6 95%CI (9.0-10.1) 9.7 95%CI (9.3-10.1) 
Restrain 10.4 95% CI (9.5-10.4) 10.0 95% CI (10.4-9.5) 
Use of emotional social support 11.5 95%CI (11.1-12.0) 10.8 95%CI (10.3-11.2) 
Substance use 10.2 95%CI (9.6-10.8) 9.3 95% CI (8.8-9.8) 
Acceptance 11.8 95% CI (11.4-12.2) 11.2 95% CI (10.8-11.7) 
Suppression 11.2 95% CI (10.8-11.6) 9.9 95% CI (9.4-10.4) 
Planning 12.0 95% CI (11.4-12.5) 10.4 95% CI (10.0-10.8) 
Domain MI/CBT mh GAP IG 
Frequency 15.2 95%CI (12.4-18.0) 17.2 95% CI (15.2-19.3) 
Severity 14.8 95%CI (12.0-17.6) 17.0 95%CI (14.9-19.2) 
Total 29.8 95% CI (24.4-35.2) 33.7 95% CI (29.6-37.8) 
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Intervention effects on alcohol use 
At three months, as shown on Table 5, there were a statistically significant reductions in 
alcohol use in both MI/CBT and mh GAP IG groups mean diff. 3.33(1.88;4.78) p <0.001, and 
2.53(1.25;3.81) p < 0.001. However, there were no statistically significant differences between the 
groups (p=0.85). However, at 6 months, the MI/CBT had a further reduction in AUDIT score that was 
statistically significant 2.41(0.99;3.83) p <0.001. There was a statistically significant difference 
between the MI/CBT and mh GAP IG at 6 months (p=0.05) as shown on Figures 2 and 3.  
 MEAN STANDRAD ERROR STANDARD DEVIATION  95%CI P-VALUE 
MI/CBT n=102      
AUDIT      
Baseline 14.85 0.63 6.34 (13.60-16.10)  
3 months 11.51 0.54 5.46 (10.45-12.60)  
Mean diff 3.33 0.72 7.39 (1.88-4.78) <0.001 
mh GAP IG n=106      
AUDIT      
Baseline 14.29 0.58 5.96 (13.14-15.44)  
3 months 11.76 0.58 6.00 (10.60-12.92)  
Mean diff 2.53 0.65 6.66 (1.25-3.81) <0.001 
MI/CBT n=86      
AUDIT      
3 months  11.23 0.57 5.32 (10.09-12.37)  
6 months 8.82 0.47 4.37 (7.89-9.76)  
Mean diff 2.41 0.71 6.62 (0.99-3.83) <0.001 
mh GAP IG n=79      
AUDIT       
3 months  11.84 0.68 6.11 (10.47-13.20)  
6 months  10.81 (0) 5.63 (9.55-12.07)  
Mean diff 1.02 0.85 7.51 (-0.66-2.70) 0.1143 
Table 8: Comparison of effect of MI/CBT and mh GAP IG on AUDs 




Figure 2: Compare MI/CBT and mh GAP IG interventions effects over 6 months. ARM GROUP 1 is the 







There were statistically significant reductions in viral load at the end of 6 months for both the 
MI/CBT 0.77(0.41;1.13) p <0.001 and mh GAP IG 0.40(-0.51;0.84) p= 0.0408 with a greater reduction 
in the MI/CBT as shown on Table 9. However, group differences were not statistically significant 
(p=0.46) at 6 months. Figure 4 shows the change in viral loads change over 6 months comparisons. 
Figure 5 shows the viral loads changes for the whole sample by individual between baseline and 6 
months. Of note is the fact that the majority of participants reduced their viral loads, however, a 
minority increased the viral loads. 
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Baseline  1.85 0.12 1.11 (1.62-2.09)  
6 months  1.07 0.15 1.40 (0.78-1.39)  
Mean diff 0.77 0.18 1.66 (0.41-1.13) <0.001 





Baseline  1.51 0.14 1.25 (1.22-1.78)  
6 months  1.11 0.17 1.53 (0.78-1.45)  
Mean diff 0.40 0.22 2.02 (-0.51-0.84) 0.0408 




Figure 3: Shows comparisons of viral loads changes from baseline to 6 months between the arms. 
ARM GROUP 1 is the MI/CBT and ARM GROUP 0 is the mh GAP IG. 
 




Figure 4: Spaghetti plot for overall viral load over 6 months.  
 
CD4 
At baseline, the MI/CBT arm had a lower CD4 compared to the mh GAP IG as shown in Table 
10 and Figure 5. At 6 months MI/CBT group improved on CD4 by MD23(-72;26.08) p=0.8231 and mh 
GAP IG MD45.07(13.05;103,20), both which were however not statistically significant. This is shown 
on Table 10. 
 
Mean Standard  Standard 
deviation  
95%CI  P value  
MI/CBT n=85      
Baseline  397.32 26.32 243.19 (344.87:449.79)  
6 months  420.35 25.58 235.85 (369.48:471.23)  
Mean diff -23.02 24.69 227.64 (72.12;26.08) 0.8231 
mh GAP IG n=81      
Baseline  463.61 25.37 228.31 (413.12:514.09)  
6 months  418.53 22.59 208.36 (373.56:463.50)  
Mean diff 45.07 29.21 262.88 (13.05:103.20) 0.0634 










0 2 4 6
time




Figure 5: Comparison of intervention effects between MI/CBT and mh GAP IG over 6 months. ARM 
GROUP 1 is the MI/CBT and ARM GROUP 0 is the mh GAP IG.  
 
Functionality  
 There were statistically significant changes in functionality for both MI/CBT (MD0.95 95% CI 
(0.10; 1.80) p=0.029) and mh GAP IG (MD 1.25 95%CI (0.39;2.52) p=0.008). However, there were no 
statistically significant differences between groups (p=0.67). 
Table 11: Comparison of arms for WHODAS 2.0 
 
Mean  Standard error  Standard 
deviation  
95%CI P-value  
MI/CBT n=102      
Baseline 14.6 0.27 4.05 14.00;16.02)  
3 months 14.6 0.29 3.01 (14.05;1519)  
6 months  15.71 0.35 3.56 (15.01:16.40)  
                Mean diff -1.05 0.46 4.64 (-1.96: -0.14) 0.025 
Mh GAP IG      
Baseline 16.5 0.38 4.10 (14.60;16.80  
3 months  15.82 0.42 4.27 (14.99:16.65)  
6 months  14.87 0.40 3.66 (14.06:15.67)  
Mean diff 1.45 0.54 4.70 (0.39:2.52) <0.001 
 




Figure 6: Comparison of WHODAS at baseline, 3 months and 6 months for both arms. ARM GROUP 1 
is the MI/CBT and ARM GROUP 0 is the mh GAP IG.  
Quality of life (QoL) 
There were statistically significant changes in the quality of life for both arms between 3 and 
6 months (MI/CBT MD-13.63 95%CI (-17.05; -10.21, p <0.001; mh GAP IG MD -12.21 95% CI (-14.71; 




Mean  Standard error Standard deviation  95%CI P value  
MI/CBT      
              Baseline 69.80 0.85 8.90 (82.85;88.10)  
3 months  73.22 0.96 9.08 (83.89;89.08)  
6 months  71.68 0.89 8.98 (69.91;73.44)  
Mean diff 1.48 1.37 12.67 (-1.24;4.19) 0.283 
MI/CBT      
            Baseline 71.00 0.75 8.45 (69.00;73.22)  
3 months  71.63 0.89 8.98 (69.91;73.44)  
6 months  86.28 1.14 14.66 (83.48;86.08)  
Mean diff -13.63 1.72 17.41 (-17.05; -10.21) <0.001 
mh GAP IG      
              Baseline 69.70 0.75 7.30 (70.32;73.40)  
3 months  71.81 0.80 7.29 (70.23;73.39)  
ARM GROUP*time; LS Means
Current effect: F(2, 370)=2.4041, p=.09176
Type III decomposition
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6 months  71.59 0.71 7.32 (70.19;72.99)  
Mean diff 0.46 1.17 10.39 (-1.87;2.78) 0.698 
mh GAP IG      
              Baseline 71.25 0.62 7.15 (69.18;73.28)  
3 months  71.59 0.71 7.32 (70.19;72.99)  
6 months  84.38 0.86 9.64 (82.68;86.08)  
Mean diff -12.21 1.26 13.03 (14.71; -9.72) <0.001 
 
Table 12:  Showing a comparison of arms for WHOQoL at baseline, 3 months and 6 months  
Figure 7: Showing an adjusted prediction of WHOQoL with 95% confidence intervals of both arms for 
































Baseline 3 months 6 months
time
armgroup=0 armgroup=1
Adjusted Predictions of WHO QOL with 95% CIs
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AUDIT  MD S.E  SD 95%CI  P-value 
At 3 months          
MI/CBT  3.33  0.72  7.39  (1.88-4.78)  < 0.001 
Mh GAP IG  2.53  0.65  6.66  (1.25-3.81)  < 0.001 
At 6 months      
MI/CBT 2.41  0.71  1.66  (0.41-1.13)  < 0.001 
Mh GAP IG  1.02  0.85  0.71  (-0.51-0.84)  0.0408 
Viral load At 6 months       
MI/CBT  0.77 0.18 1.66 (0.41-1.13)  < 0.001 
Mh GAP IG  0.40 0.22 2.02 (-0.51-0.84)  0.0408 
CD4 at 6 months      
MI/CBT  -23.02  24.69 227.64 (-72.12; 26.08)  0.8231 
Mh GAP IG  45.07 29.21 262.88 (-13.05;103.20) 0.0634 
WHODAS at 3 months       
MI/CBT  -1.05 0.46 4.64 (-1.96; -0.14)  0.025 
Mh GAP  0.26 0.69 7.07 (-1.10;1.62)  0.706 
At 6 months       
MI/CBT  0.95 0.43 3.97 (0.10;1.80)  0.029 
Mh GAP IG  1.45 0.54 4.70 (0.39;2.52)  <0.001 
WHOQOL        
At 3 months 
   
 
 
MI/CBT  1.48 1.37 12.67 (24;4.19)  0.283 
Mh GAP IG  0.46 1.17 10.39 (-1.87;2.78) 0.698 
At 6 months       
MI/CBT  -13.63 1.72 17.41 (-17.05; -10.21) <0.001  
Mh GAP IG  -12.21 1.26 13.03 (-14.71; -9.72) <0.001  
Table 13: is showing a summary of outcomes. The outcomes include AUDIT, VIRAL LOAD, CD4 and 





This two-arm study demonstrated significant effects on alcohol use reduction in PLWH. 
Further, interventions showed effects on viral loads and the MI/CBT caused some modest 
improvement in CD4 count. The interventions for problematic alcohol use led to improvement in 
functionality and quality of life. These are significant findings in light of a few trials that have been 
done that showed no effects on alcohol use in PLWH(22, 28, 56).  More important is the fact that the 
intervention was delivered within the usual HIV care setting, by nurses who are involved in the day-
to-day care of HIV patients. This finding suggests that, integration of management of alcohol use 
within the usual care for HIV is feasible. The effects of the study may be related to it being “imbedded” 
within the day to day HIV care. Task sharing and integration have been key in the success of not only 
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HIV care upscaling but also stigma reduction(57-59). The same success in task sharing and integration 
in alcohol use management are possible and can give equally good results. This may eliminate stigma 
associated with both HIV and alcohol use. Stigma for both HIV and alcohol consumption have been 
shown to be some of the barriers to uptake of interventions for problematic alcohol use by PLWH(30). 
The participants were in the mh GAP IG in our study benefited from the intervention up to 
three months. Current research data shows that the effects of interventions for problematic alcohol 
use are not prolonged beyond three months(22, 60). It also seems that in this study exposure to 
intervention was good enough to cause effects on alcohol use and other treatment outcomes. The 
prolonged effects in the MI/CBT arm maybe due to booster sessions. These findings have important 
implications. They demonstrate the need for booster sessions through continued contact and 
feedback. This is in keeping with recent recommendations about booster sessions by a recent 
systematic review(22). These booster sessions can come in the form of brief discussions of current 
alcohol consumption at medication refill encounters or through use of mobile mHealth technologies. 
Mobile health technologies have been shown to be low cost and aid the effects of motivational 
interviewing (61). Besides the need for booster sessions, the findings of this study suggest that the 
mh GAP IG is able to reduce the AUDIT score, but only for a period. Even though the periods were 
short, as the country roles out the mh GAP IG, emphasis should be made on reaching all individuals 
and conditions. This will also help in integration of mental health in HIV care and primary health care. 
Further, the success of our intervention can be attributed to provision of feedback on the 
patients’ viral loads and CD4. This is especially so, as the usual HIV care in Zimbabwe did not include 
this feedback as the viral loads.  Personal feedback especially using mobile health technologies can 
be a key component of motivating desire for change in future interventions(62, 63). Exposure to 
alcohol intervention and feedback has been shown to lead to change in the drinking behaviour(64). 
This approach is feasible as mobile phone penetrance improve in LMIC. 
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This study demonstrated a statistically significant drop in the viral load of both the MI/CBT 
and mh GAP IG, although it was more so on the MI/CBT. The change in the viral loads is important 
especially in Zimbabwe, where a recent population based survey on HIV care and 90-90-90 targets 
were assessed that showed that 75% had viral suppression, that fall short of the 90% as required by 
90-90-90 UNAIDs strategy(2, 65). This reduction in viral loads suggest that the adherence to 
treatment improved as a result of the interventions. Virological control is key in the HIV treatment 
cascade (66). Viral load reduction reduces infectiousness thus it is useful in preventing new 
infections(67).  Addition of interventions for problematic alcohol use in the HIV care program in 
Zimbabwe and other HIV high burden countries is essential for them to reach the 2020 goal of 90-90-
90. 
 There was some modest improvement of CD4 in the MI/CBT.  Overall, this suggest that 
intervention for alcohol use have the effect of improving HIV treatment outcomes. The magnitude of 
CD4 change is however not unexpected given the recent findings in similar studies Wandera et 
al(2017) from Uganda found hazardous alcohol consumption not related to CD4 suggesting that CD4 
count measure may not be an important marker of poor adherence (68) and initiation of HIV 
treatment in individuals with alcohol consumption did not affect the CD4 cells count in another 
study(69). However, a study in Brazil found alcohol consumption associated with low CD4 count(70). 
This suggests that there may exist some ways that alcohol use interacts with CD4 independent of ART 
and adherence(71). These findings suggest that CD4 on its own is not a good measure of effectiveness 
of HIV treatment. 
Our study showed that intervention for problematic alcohol use lead to improvement in the 
functionality as measured by WHODAS 2.0 score. This is an important finding and suggest that 
validation and use of such scales needs to be done in the HIV clinics.  Functionality in PLWH on ART 
has been known to be compromised especially in patients with poor adherence and depression(72). 
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In addition presence of physical symptoms has also been shown to lead to reduced function in the 
domains of participation and mobility in PLWH(73). As PLWH frequently face a reduction in function 
and limited activity, which also affect adherence, routine monitoring of functionality has been 
recommended(72). In HIV care clinics like in Zimbabwe, this may need a small, but important cost of 
validation of the tools. 
This study showed that reduction in alcohol use and clinical improvement was associated with 
improvement in quality of life. It has been shown that poor quality of life is associated with reduced 
adherence to treatments of other chronic conditions such as hypertension and other chronic 
conditions(74). Quality of life reduces adherence and poor adherence leads to poor quality of life.   
Improved quality of life has been shown to promote adherence to HIV treatment(75). It is essential 
that the PLWH have both physical recovery and experience good quality with their lives. 
Participants in this study had substantial comorbidities especially depression and anxiety.  
Future interventions for problematic alcohol use must include sections that target both depression 
and/or anxiety as well.  The psychological treatments that target several comorbities have already 
been done. These comorbities need to be reconsidered at scale-up as they may have influenced the 
outcomes from this study. A study in India by Patel V et al (2017) showed that depression and alcohol 
can be treated in the same clinic using manualised interventions(76). The RGNs in the HIV care clinics 
can thus be trained to deliver HIV care and psychological treatments for depression and/or anxiety 
and alcohol in an integrated setting. Calls have indeed been made to integrate mental health services 
into the existing primary health care services in order to narrow the mental health treatment gap(77). 
The present study findings should be taken together with other on-going initiatives in mental health 
in Zimbabwe. These include the TENDAI studies and the Friendship Bench, both of which aim to utilise 
lay-health care workers to treat depression in PLWH and common mental disorders in the general 
population respectively(78-80). 
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This study has several limitations. First, the RCT was a cluster randomised controlled trial and 
the clusters were different in sizes, resulting in failing to recruit same numbers of participants in the 
clusters. This has the effect of loss of power in the study. Selection of cluster was however, by 
randomisation and participants were randomly selected using computer databases to reduce 
selection bias. Secondly, the study had significant loss to follow up especially in the mh GAP IG arm. 
This could have resulted in the loss of power.  Third, the alcohol use measure was the AUDIT score. 
This is a self-report questionnaire which is subject to social desirability bias(81). Methods such as use 
of automated computer assisted self-interview (ACASI) or electronic assessments maybe useful in 
reducing social desirability bias(82). Fourth, the mh GAP IG experienced more loss compared to the 
MI/CBT and resulting in attrition bias. Lastly, the AUDIT, the WHODAS 2.0 and WHOQOL have not 
been validated in Zimbabwe PLWH. 
Notwithstanding these limitations, we believe our study has findings that are important. As   
the country continues to improve HIV care treatments in order to attain the 90-90-90 targets, 
problematic alcohol use maybe the next frontier. Most levels of HIV care were represented so the 
findings can be generalised for all the clinics in Zimbabwe.  
Conclusion 
This is the first study in Zimbabwe to demonstrate the effectiveness of a psychological 
interventions for problematic alcohol use in PLWH delivered in a task sharing model within HIV clinics. 
This has important implications. Alcohol use in HIV infected patients can be managed in clinics by 
nurses who have been trained. More staff need to be recruited though, as the participants will require 
additional time with RGNs. The additional time required for HIV/alcohol use counselling may affect 
nurse’s routine duties. As a result, the clinics may need adjustment to accommodate the changes. 
The interventions led to improvement in functionality and quality of life. This is important as quality 
of life and functionality are important determinants of HIV treatment outcomes. 
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 As the AUDIT is a self-report, it is not the ideal tool to use alone especially in these populations 
whose alcohol consumption though low or moderate may lead to more damage in the body. Use of 
alcohol biomarkers is thus recommended.  
Finally, as the study experienced significant loss to follow up, mechanisms to retain 
participants need to be developed.  Use of mobile technology may also be employed to reduce the 
need of patients face-to-face with intervention staff. We therefore call for effectiveness trials that 
consider current HIV treatment settings complexity, current staffing and their knowledge of alcohol 
use/HIV interface and involvement of patients in design and participants retention techniques. 
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Although alcohol use is associated with HIV transmission, adherence to treatment, increased 
physiologic harm and worse retention in care yet, few clinical trials targeting unhealthy alcohol use 
in people living with HIV (PLWH) have been undertaken (Brown, DeMartini, Sales, Swartzendruber, & 
DiClemente, 2013; Justice et al., 2016; Marshall et al., 2017; Monroe et al., 2016). A recent systematic 
review found alcohol use was one of the key determining factors of adherence to HIV treatment(Azar, 
Springer, Meyer, & Altice, 2010; Heestermans, Browne, Aitken, Vervoort, & Klipstein-Grobusch, 
2016). Research on psychological or behavioural interventions for alcohol use have not provided 
consistent evidence for their effectiveness in PLWH(Brown et al., 2013; Samet & Walley, 2010).  
While, Zimbabwe has 1.6 million PLWH and 6.0 litres per capita alcohol consumption and the 
deleterious effects of the combination of HIV and alcohol use are known, the Zimbabwe National 
AIDS Council 2015-2020 HIV Strategy, has  no policy initiatives that address alcohol use 
(nac.org.zw/hiv-and-aids-situation/; 
www.who.int/substance_abuse/publications/global_alcohol_report/profiles/en/). The aim of this 
dissertation was to assess the effectiveness of psychological interventions for alcohol use in PLWH 
through a cluster randomised controlled trial (RCT) in order to inform future policy on interventions 
for them in Zimbabwe.  
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Systematic review of interventions for alcohol use disorders 
A systematic review to synthesize the evidence of the effectiveness of psychological 
interventions for unhealthy alcohol use in PLWH was carried done. The primary outcome for the 
review was a reduction in the frequency of alcohol use. The secondary outcomes were the effects of 
the interventions on CD4 count, viral load, other substances use, risky sexual behaviour and quality 
of life. The participants were PLWH receiving care at hospitals, clinics and communities. Experimental 
studies have shown that the daily allowable alcohol intake for PLWH, especially if they have not 
achieved viral suppression, needs to be lower than 21 units per week for males and 14 units per week 
for females as PLWH, they need less alcohol to get intoxicated and suffer physiologic harm from a 
lower quantities of alcohol(Braithwaite et al., 2008; Cook et al., 2017; Justice et al., 2016; McGinnis 
et al., 2016). Damage to the liver due to alcohol use and hepatitis C, which are both associated with 
HIV, have been associated with a reduction in the effectiveness of antiretroviral therapy and poorer 
treatment response(Fuster et al., 2016; Kresina et al., 2002; Sonderup & Wainwright, 2017).  Both the 
quantity and the frequency of alcohol intake have been found to adversely affect viral 
suppression(Braithwaite et al., 2005; Canan et al., 2017). 
Our review identified 14 studies that met the eligibility criteria, three from Africa and the rest 
from US. Heterogeneity in the measurement of alcohol use outcomes did not allow for a meta-
analysis to be carried out. The overall quality of studies was moderate to low on account of selection 
and attrition biases. The main findings of the review were that (i) motivational interviewing alone and 
with adjunctive mobile technology and (ii) cognitive behavioural therapy alone reduced alcohol 
consumption frequency. The findings of our review are similar to two previous systematic 
reviews(Brown et al, 2013 and Samet et al, 2010) but differed from a recent systematic review by 
Scott-Sheldon et al (2017), who found evidence for behavioural/psychological interventions on 
alcohol consumption, condom use and adherence to treatment in PLWH(Brown et al., 2013; Samet 
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& Walley, 2010; Scott-Sheldon, Carey, Johnson, Carey, & Team, 2017). More randomised controlled 
trials are needed in low- and medium-income countries (LMIC) that have high HIV disease 
burden(Brown et al., 2013). We also recommend that effectiveness trials target alcohol use 
specifically and use uniform alcohol use measures. 
Development of the intervention protocol 
There is evidence that motivational interviewing is effective in improving adherence to ART, 
reduction in risky sexual behaviour, reduction in substance abuse and can lead to reduction in viral 
load(Hasin et al., 2013; Parsons, Golub, Rosof, & Holder, 2007). Alcohol use can be a maladaptive 
coping mechanism for the psychosocial stressors that PLWH face(Elliott, Aharonovich, O'Leary, 
Wainberg, & Hasin, 2014). As such, adaptive skills to cope with mental health problems and other 
stressors based on cognitive behavioural therapies(CBT) and problem-solving techniques are 
needed(Sikkema et al., 2015). CBT, combined with motivational interviewing or motivational 
interviewing combined with problem solving techniques have been used in some studies(Parry et al., 
2014; Parsons et al., 2007).There is therefore heterogeneity in the interventions content. Specialist 
psychosocial workers are needed to deliver these interventions. However, there is shortage of 
specialized skilled personnel such as psychologists in most countries  and the World Health 
Organisation has called from task sharing as a solution(Organization, 2008). 
The experience of adapting evidence-based therapies is essential. This because, there are 
contextual factors such as language, cultures and traditions that need to be considered(Bernal & 
Adames, 2017; LeBron et al., 2014). 
Alcohol use is associated with non-adherence to HIV treatment, sexually transmitted 
infections (STIs), HIV spread and poor HIV treatment outcomes(Fisher, Bang, & Kapiga, 2007; Hahn & 
Samet, 2010; Heestermans et al., 2016). Recommendations to develop and implement interventions 
for unhealthy alcohol use in PLWH have been made(Brown et al., 2013; Chander, Hutton, Lau, Xu, & 
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McCaul, 2015).  A review of literature on interventions for unhealthy alcohol use, in-depth interviews 
with experts and focus group discussions with PLWH were some of the activities undertaken in the 
formative work. Further, a qualitative study on the perceptions, barriers and facilitators to 
interventions for unhealthy alcohol use in PLWH, a pilot and feasibility study of intervention for 
unhealthy alcohol use in PLWH and meetings with experts were held to come up with the final version 
that was to be used in the Cluster randomised controlled trial (RCT).  A cluster RCT design was chosen 
for the delivery of a community-based motivational interviewing/cognitive behavioural therapy 
(MI/CBT) intervention to reduce the risk of contamination and to improve administrative efficiency 
(Hayes R). To permit generalizability, all HIV clinics in Zimbabwe were eligible to take part in the study.  
The control in the study protocol was the World Health Organisation mental health GAP 
Intervention Guide (mh GAP IG) for patients with mental, neurological and substance use disorders, 
as has been employed in other studies(Nadkarni et al., 2015; Organisation, 2010). 
Perceptions of alcohol use in PLWH 
A qualitative study was conducted as part of the formative work for the intervention for 
alcohol use. The aim of the study was to understand patients’ perceptions of alcohol use in the 
context of HIV treatment. Clinics were chosen to represent the tertiary care, secondary care and 
church related institutions or district hospitals, the current set-up in HIV care in Zimbabwe. The main 
findings were that (i) participants had adequate knowledge of the effects of alcohol use when one is 
on HIV treatment. (ii) Participants were able to identify direct effects of alcohol use on the body such 
as liver disease. (iii) Indirect effects of alcohol use when one is on HIV treatment such non-adherence 
to treatment and involvement in risky life styles such as involvement in sex without protection. (iv) 
Stigma that HIV and alcohol face. Participants also proffered solutions such as (i)additional training 
of nurses in HIV and alcohol use interface (ii)use of primary care counsellors in providing interventions 
(iii) need for change in attitudes towards HIV and in the HIV care staff. 
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These findings suggest that the HIV health education that is provided to patients is accurate 
and probably sufficient. It also suggests that HIV literacy levels were high among PLWH. However, 
there are high levels of stigma towards alcohol use and HIV.  Person-cantered interventions for 
alcohol use which do not have diagnostic ‘labels’ such as ‘alcoholic’ or similar need to be implemented 
in order to reduce stigma(Robinson, 2017). Further, offering HIV treatment and interventions for 
alcohol use within the same premises and by the same staff attending to other health conditions may 
help reduce stigma(Church et al., 2013). Integration of mental health services with other health care 
services has been recommended as a way to improve treatment, reduce the treatment gaps, 
treatment outcomes and reduction of stigma(Patel et al., 2016). Due to the high levels of knowledge 
about the effects of alcohol consumption on HIV care, interventions for alcohol use can be made a 
routine practice in HIV care clinic without need for additional staff.  More research in effectiveness 
trials of interventions for unhealthy alcohol use need to be done incorporating stigma reduction 
strategies in HIV care. These interventions must incorporate the views of patients in order to improve 
their acceptability(Fredericksen et al., 2015). 
Pilot and feasibility study 
In preparation for the main trial, a pilot and feasibility study were carried out. The aim was to 
assess (i) the feasibility of screening for alcohol use, (ii) the utility of the assessment tools, and the 
(iii) delivery of the interventions using a task sharing model.  At the end of three months there was 
statistically significant change in AUDIT score and CD4. However, the study had a small sample size of 
40 and was not adequately powered. This study however provided initial evidence of feasibility of the 
intervention (MI/CBT or MH GAP IG) in an HIV care clinic. The study found that it was feasible to 
recruit HIV positive individuals with unhealthy alcohol use among PLWH. Further, nurses were trained 
in delivering an unhealthy alcohol use intervention. Owing to significant loss to follow up, the main 
trial had to incorporate strategies to retain participants. 
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The findings from this study are important given that most of the studies have been shown to 
lack effectiveness in reducing alcohol consumption in PLWH(Brown et al., 2013; Samet & Walley, 
2010). As the registered general nurses were selected to deliver the interventions for unhealthy 
alcohol use, the study findings showed that it was feasible to deliver the interventions within the 
same setting delivering HIV care. The amount of time to deliver MI/CBT intervention requirements 
were determined and helped in the planning of the RCT. Loss to follow-up was a limitation of the pilot 
and feasibility study. This helped the main trial to finalize the sample size by incorporating loss to 
follow up percentage in the sample size. 
Intervention for unhealthy alcohol use: a cluster randomised controlled trial 
The formative studies outlined above culminated in a cluster RCT to assess the effectiveness 
of a motivational interviewing- cognitive behavioural (MI/CBT) intervention.   234 PLWH were 
enrolled from randomly selected 16 HIV care clinics across Zimbabwe. The intervention used a task-
sharing model to deliver the intervention.  Our RCT blended motivational interviewing and CBT in the 
intervention for alcohol use based on this evidence. As the HIV care program includes counselling and 
testing, ART initiation and follow up and is nurse-led, registered general nurses (RGN) were chosen 
to deliver the intervention. Participants were followed up for 6 months post-intervention. This is the 
first study to test the effectiveness of interventions for alcohol use in PLWH in Zimbabwe. 
 The two arms showed statistically significant changes in AUDIT scores (MD) at 3 months. 
However, the MI/CBT showed further improvement at 6 months, with the change between 3 and 6 
months being statistically significant. The lack of a further improvement between 3 and 6 months in 
the mh GAP IG with continued improvement in the MI/CBT may be attributed to booster sessions 
given to MI/CBT arm. A number of studies have shown that intervention for unhealthy alcohol use 
have reduced effects over time and booster sessions have been recommended (Parsons et al., 2007; 
Samet & Walley, 2010). The mh GAP IG was developed for primary care settings 
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(www.who.int/mental_health/publications/mhGAP_intervention_guide/en/). The findings on the 
mh GAP IG effectiveness, albeit for 3 months is important as it can be adopted at HIV care clinic 
settings allowing for integration of mental, neurological and substance use in routine HIV treatment 
thus, to narrowing the treatment 
gap(www.who.int/mental_health/publications/mhGAP_intervention_guide/en/). Due to multiple 
comorbidities such as depression identified in this population, an intervention for unhealthy alcohol 
use should include treatment for depression using a transdiagnostic approach in HIV care patients as 
has been recommended by recent systematic reviews(Balhara, Gupta, & Elwadhi, 2017; Vujanovic et 
al., 2017). 
 There were reductions in viral loads for both the MI/CBT and the mh GAP IG at 6 months. 
However, there were modest changes in CD4 for both the MI/CBT. Functionality also improved for 
both arms at 6 months. Quality of life also improved over the follow-up period for both MI/CBT and 
the mh GAP IG interventions. 
Findings from this study are important.  They suggest that interventions for unhealthy alcohol 
use in PLWH can be effective in improving HIV viral loads through improvement in adherence. Such a 
finding is similar to findings from other studies(Naar-King et al., 2008; Parsons et al., 2007). Many 
studies have shown a strong relationship between the viral loads increase and alcohol use, both the 
in terms of quantities of alcohol taken and frequency of drinking(Braithwaite et al., 2005; Cook et al., 
2017; Williams et al., 2016). Research suggests that PLWH with alcohol use require low daily allowable 
quantities of alcohol as compared to those living without HIV (Braithwaite et al., 2008). Further PLWH 
with detectable viral loads require less quantities of alcohol to get intoxicated(McGinnis et al., 2016). 
PLWH have also been shown to suffer more physiologic harm at low levels of alcohol 
consumption(Justice et al., 2016). Yet viral load suppression is associated with reduced HIV 
transmission and lack of viral suppression may increase HIV transmission(Ross et al., 2018). 
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Adherence is the most important determinant of treatment outcomes and unhealthy alcohol use 
have been associated with poor adherence and non-engagement with treatment(Azar et al., 2010; 
Galvan et al., 2002). 
The findings on CD4 are in keeping with other studies from elsewhere. Wandera et al (2017) 
showed that hazardous alcohol use is not associated with lower CD4 count, yet Malbergier et al 
(2015)(Malbergier, Amaral, & Cardoso, 2015) found alcohol dependence to be associated with lower 
CD4 count (Wandera et al., 2017). Hahn et al (2018) found unhealth alcohol having apparent effect 
on CD4 in the short term(Hahn et al., 2018) while Kolwaski et al (2012) found alcohol consumption 
having no effect on people initiating antiretroviral therapy(Kowalski et al., 2012). However, findings 
from other studies are contrary. In a study that used the AUDIT score as a measure da Silva et al 
(2017) found that a high AUDIT score was associated with a low CD4(da Silva, Mendoza-Sassi, da 
Mota, Nader, & de Martinez, 2017). Both MI/CBT and mh GAP IG led to improvement in functionality 
and quality of life. Good quality of life has been shown to improve adherence to HIV 
treatment(Aranda-Naranjo, 2004). 
Evidence for the effectiveness of alcohol use reduction interventions in HIV is weak, in spite 
of the burden and need(Brown et al., 2013; Samet & Walley, 2010). This dissertation demonstrates 
the feasibility of adapting an evidence-based intervention for alcohol use disorders that can be 
delivered in a low resource setting. However, it is important to incorporate patients’ perceptions and 
expectations in the development of any intervention. Further, brief interventions for unhealthy 
alcohol use such as the mh GAP IG can result in reduction in alcohol use over a short period as shown 
in this study. It may however require booster sessions that may come in the form of short messages 
using mobile platforms such found by Hasin et al (2013) in the use of HealthCall(Hasin, Aharonovich, 
& Greenstein, 2014).  Functionality and quality of life also improve with improved HIV treatment 
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adherence. It is thus essential to incorporate functionality and quality of life measures in routine HIV 
treatment settings.  
Overall, this is the first study to enrol nurses to deliver an intervention for unhealthy alcohol 
us at HIV care clinics using a task sharing model. With the results achieved in this study, there is scope 
for upscaling MI/CBT intervention for unhealthy alcohol use to include more clinics. Further, the 
improvement in viral load control will go a long way in helping the country achieve the UNAIDS 90-
90-90 goals(Organization, 2017; UNAIDS, 2018). Program planning for PLWH must include 
interventions for unhealthy alcohol use, substance use disorders and common mental disorders 
treatments in order to improve treatment HIV treatment outcomes. 
This project had substantial limitations. The RCT was a cluster randomised controlled trial and 
the clusters were different in sizes, resulting in failing to recruit same numbers of participants. This 
has the effect of loss of power in the study. Selection of cluster was however, by randomisation and 
participants were randomly selected using computer databases to reduce selection bias. 
 Further there is paucity of intervention studies in low- and medium-income countries with a 
high HIV disease burden. As a result, most of the studies reviewed came from high income countries 
and most of the evidence was indirect. The Alcohol Use Disorders Identification Test (AUDIT) that was 
used in assessing alcohol use is a self-report questionnaire and suffer from social desirability bias. 
Besides, the AUDIT has not been validated in PLWH in Zimbabwe. This is the same case as other tools 
used in this project such as the WHODAS 2.0 and the WHOQOL. The RCT had significant loss to follow-
up especially in the mg GAP IG arm and could have lost power. 
However, despite these limitations, we believe the study makes a significant contribution to 
HIV care in Zimbabwe. The study showed that even with minimum funding and no increase in 
personnel, an intervention for alcohol use is feasible. This intervention resulted in reduction in alcohol 
use and reduction in viral load. Nurses provide HIV care services in many high HIV burden countries, 
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and the study showed that they can also deliver interventions for unhealthy alcohol use effectively.  
As adherence to ART is an important predictor of HIV treatment outcomes and alcohol has been 
shown to impact negatively on adherence, the findings in this study will improve the HIV treatment 
outcomes if implemented. 
This study is one of a few interventions for problematic alcohol use to demonstrate 
effectiveness in alcohol use reduction, viral load reduction, functional improvement and 
improvement in quality of life in a LMIC. More effectiveness trials of interventions for unhealthy 
alcohol use need to be carried out, as these improvements will go a long way in helping the countries 
in achieving the 90-90-90 UNAIDS targets. HIV care programs must incorporate interventions for 
unhealthy alcohol use in order to improve HIV treatment outcomes. Unhealthy alcohol use and HIV 
treatment collaborations provide an opportunity for integrating mental health in other health care 
programs that may result in narrowing the mental health treatment gap.  Problematic alcohol use 
has been associated with virological failure, suggesting that when doing HIV treatment outcome 
assessment, assessment of unhealthy alcohol use must be done concurrently. A brief intervention for 
unhealthy alcohol use such as mh GAP IG resulted in improved viral suppression. Effectiveness trials 
that target unhealthy alcohol use outcomes must include treatment outcomes such as viral loads. 
Quality of life and functionality must be measured routinely in HIV care programs, as improved 
function and better quality of life are associated with better adherence to HIV treatment. 
As a way forward, the findings from this study may help inform other initiatives such as the 
Friendship Bench and Tendai that aim at treating common mental disorders and depression in HIV 
that are ongoing in a as synergistic way. This will also help in scaling up psychological therapies. 
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